{"content":"<li class=\"n-box-item date-title\" data-end=\"1554350399\" data-start=\"1554264000\" data-txt=\"Monday, December 23, 2019\">Wednesday, April  3, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3448281\" data-ts=\"1554327388\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448281-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/MKTX' title='MarketAxess Holdings Inc.'>MKTX</a> <font color=\"green\">+3.8%</font>. <a href='https://seekingalpha.com/symbol/WTRE' title='Watford Holdings Ltd.'>WTRE</a> <font color=\"green\">+3.1%</font>. <a href='https://seekingalpha.com/symbol/CBLK' title='Carbon Black, Inc.'>CBLK</a> <font color=\"green\">+3.1%</font>. <a href='https://seekingalpha.com/symbol/PRNB' title='Principia Biopharma Inc.'>PRNB</a> <font color=\"green\">+2.1%</font>. <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color=\"green\">+1.7%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color=\"red\">-28.5%</font>. <a href='https://seekingalpha.com/symbol/RECN' title='Resources Connection, Inc.'>RECN</a> <font color=\"red\">-10.6%</font>. <a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a> <font color=\"red\">-7.4%</font>. <a href='https://seekingalpha.com/symbol/PARR' title='Par Pacific Holdings, Inc.'>PARR</a> <font color=\"red\">-4.8%</font>. <a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a> <font color=\"red\">-3.6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448281\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MKTX $WTRE $CBLK - After Hours Gainers / Losers https://seekingalpha.com/news/3448281-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448281-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448274\" data-ts=\"1554326319\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448274-pluristemminus-12_9-on-proposed-public-offering-direct-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pluristem -12.9% on proposed public offering, direct offering</a></h4><ul>   <li>Pluristem Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics Inc.'>PSTI</a>) is <font color=\"red\">12.9% lower</font> after hours following a <a href=\"https://seekingalpha.com/pr/17466006-pluristem-therapeutics-inc-announces-proposed-public-offering-common-stock-warrants\" target=\"_blank\">proposal to offer shares and warrants</a> in a public offering, along with a concurrent registered direct offering.</li>    <li>Via Ladenburg Thalmann, the company will sell all shares and warrants.</li>    <li>The underwriter will get a 30-day greenshoe option to buy up to an additional 15% of shares/warrants in the public offering.</li>    <li>Proceeds of both offerings will fund research and product development activities, clinical trial activities, investment in capital equipment and general purposes.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448274\" data-linked=\"Pluristem -12.9% on proposed public offering, direct offering\" data-tweet=\"$PSTI - Pluristem -12.9% on proposed public offering, direct offering https://seekingalpha.com/news/3448274-pluristemminus-12_9-on-proposed-public-offering-direct-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448274-pluristemminus-12_9-on-proposed-public-offering-direct-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448264\" data-ts=\"1554325184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBLK\" target=\"_blank\">CBLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448264-carbon-blackplus-3-on-outperform-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carbon Black +3% on Outperform start</a></h4><ul><li>Baird starts Carbon Black (NASDAQ:<a href='https://seekingalpha.com/symbol/CBLK' title='Carbon Black, Inc.'>CBLK</a>) at Outperform with a $20 price target, implying a 43% upside.</li><li>In February, CBLK shares <a href=\"https://seekingalpha.com/news/3435347-carbon-black-minus-14-percent-downside-outlook-cfo-resignation\" target=\"_blank\">plunged</a> after the Q4 report included a downside Q1 outlook and notice of the CFO's departure. The company has since <a href=\"https://seekingalpha.com/news/3444032-carbon-black-taps-emc-vet-cfo\" target=\"_blank\">filled the role</a> with EMC veteran Steve Webber.</li><li>Carbon Black shares are <font color=\"green\">up 3%</font> after hours to $14.45.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448264\" data-linked=\"Carbon Black +3% on Outperform start\" data-tweet=\"$CBLK - Carbon Black +3% on Outperform start https://seekingalpha.com/news/3448264-carbon-blackplus-3-on-outperform-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3448264-carbon-blackplus-3-on-outperform-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448262\" data-ts=\"1554324788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMAR\" target=\"_blank\">SMAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448262-smartsheet-gains-on-outperform-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smartsheet gains on Outperform start</a></h4><ul><li>Oppenheimer initiates Smartsheet (NYSE:<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet Inc.'>SMAR</a>) at Outperform with a $50 price target.</li><li>The rating is a return to strength for SMAR, which <a href=\"https://seekingalpha.com/news/3445143-smartsheet-minus-9-percent-first-neutral-rating\" target=\"_blank\">received</a> its first Neutral rating last month when D.A. Davidson went against the Buy-equivalent grain.</li><li>Smartsheet shares are <font color=\"green\">up 1.5%</font> after hours to $40.80.</li><li>Update with more information about the upgrade:</li><li>Analyst Ittai Kidron says the strong rally is likely to continue with more customer adds and deeper penetration into existing ones.</li><li>Kidron sees incremental TAM expansion as the company expands its platform to address more use cases.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448262\" data-linked=\"Smartsheet gains on Outperform start\" data-tweet=\"$SMAR - Smartsheet gains on Outperform start https://seekingalpha.com/news/3448262-smartsheet-gains-on-outperform-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3448262-smartsheet-gains-on-outperform-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448261\" data-ts=\"1554324633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STZ\" target=\"_blank\">STZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448261-constellation-to-sell-30-wine-brands-to-gallo-in-1_7b-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Constellation to sell ~30 wine brands to Gallo in $1.7B deal</a></h4><ul><li>Constellation Brands (NYSE:<a href='https://seekingalpha.com/symbol/STZ' title='Constellation Brands, Inc.'>STZ</a>) <font color=\"red\">-1.5%</font> after-hours after <a href=\"https://seekingalpha.com/pr/17465991-constellation-brands-repositions-wine-spirits-business-accelerate-growth-increase-shareholder\" target=\"_blank\">agreeing to sell</a> ~30 brands from its wine and spirits portfolio and related facilities to E. &amp; J. Gallo Winery for $1.7B.</li><li>STZ says the wine and spirits brands to be sold, such as Clos du Bois, Black Box and Mark West, are principally priced at $11 retail and below, and do not include its Robert Mondavi, Prisoner Wine, Kim Crawford, Ruffino, Meiomi and SVEDKA Vodka brands.</li><li>STZ says the sale, which confirms <a href=\"https://seekingalpha.com/news/3443421-constellation-nears-deal-sell-wine-brands-gallo-cnbc\" target=\"_blank\">earlier speculation</a>, better aligns its portfolio with consumer premiumization trends.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448261\" data-linked=\"Constellation to sell ~30 wine brands to Gallo in $1.7B deal\" data-tweet=\"$STZ - Constellation to sell ~30 wine brands to Gallo in $1.7B deal https://seekingalpha.com/news/3448261-constellation-to-sell-30-wine-brands-to-gallo-in-1_7b-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3448261-constellation-to-sell-30-wine-brands-to-gallo-in-1_7b-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448259\" data-ts=\"1554324486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYV\" target=\"_blank\">LYV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448259-live-nationminus-1_6-after-evercore-moves-to-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Live Nation -1.6% after Evercore moves to sidelines</a></h4><ul>   <li>Live Nation (NYSE:<a href='https://seekingalpha.com/symbol/LYV' title='Live Nation Entertainment, Inc.'>LYV</a>) is <font color=\"red\">off 1.6%</font> after hours following a downgrade to In-Line by Evercore ISI, from Outperform.</li>    <li>Closing at $64.82 today, the stock's hit analyst David Joyce's price target of $64, he says. And the stock's absolute and relative EV/EBITDA multiple has hit a 10-year high.</li>    <li>He still likes the business model, growth opportunities and execution track record but sees some challenging Ticketing AOI comps in a seasonally light Q1. (h/t Bloomberg)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448259\" data-linked=\"Live Nation -1.6% after Evercore moves to sidelines\" data-tweet=\"$LYV - Live Nation -1.6% after Evercore moves to sidelines https://seekingalpha.com/news/3448259-live-nationminus-1_6-after-evercore-moves-to-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3448259-live-nationminus-1_6-after-evercore-moves-to-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448257\" data-ts=\"1554324033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REPH\" target=\"_blank\">REPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448257-recro-pharma-up-17-on-reorg-plan-bullish-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recro Pharma up 17% on reorg plan, bullish outlook</a></h4><ul><li>Taking action after the FDA rejected IV meloxicam a second time, Recro Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/REPH' title='Recro Pharma, Inc.'>REPH</a>) has launched a <a href=\"https://seekingalpha.com/pr/17465930-recro-pharma-restructures-acute-care-segment-continuing-execute-strong-cdmo-segment\" target=\"_blank\">cost-cutting initiative</a> in its Acute Care business, including the termination of about 50 employees, that it believes will significantly lower operating expenses and cash consumption. Management says the move will result in breakeven cash flow in Q3 and positive cash flow in Q4.</li><li>The company plans to meet with the FDA to discuss the second CRL and clarify a registration path forward while vetting potential commercialization partners for the product.</li><li>In a show of confidence, management has upped its 2019 revenue forecast to $85M - 87M from $80M and non-GAAP EBITDA to $38M - 40M from $34M.</li><li>Shares are up <font color=\"green\">17%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448257\" data-linked=\"Recro Pharma up 17% on reorg plan, bullish outlook\" data-tweet=\"$REPH - Recro Pharma up 17% on reorg plan, bullish outlook https://seekingalpha.com/news/3448257-recro-pharma-up-17-on-reorg-plan-bullish-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3448257-recro-pharma-up-17-on-reorg-plan-bullish-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448250\" data-ts=\"1554323889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPD\" target=\"_blank\">RPD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448250-rapid7-plus-1_3-on-outperform-start\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rapid7 +1.3% on Outperform start</a></h4><ul><li>Baird <a href=\"https://seekingalpha.com/news/3447657-rapid7-acquires-netfort\" target=\"_blank\">initiates</a> Rapid7 (NASDAQ:<a href='https://seekingalpha.com/symbol/RPD' title='Rapid7, Inc.'>RPD</a>) at Outperform with a $58 price target.</li><li>Yesterday, Rapid7 announced the acquisition of network visibility solution provider NetFort.</li><li>Rapid7 shares are <font color=\"green\">up 1.3%</font> after hours to $54.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448250\" data-linked=\"Rapid7 +1.3% on Outperform start\" data-tweet=\"$RPD - Rapid7 +1.3% on Outperform start https://seekingalpha.com/news/3448250-rapid7-plus-1_3-on-outperform-start?source=tweet\" data-url=\"https://seekingalpha.com/news/3448250-rapid7-plus-1_3-on-outperform-start\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448240\" data-ts=\"1554323240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DBVT\" target=\"_blank\">DBVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448240-dbv-tech-launches-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DBV Tech launches equity offering</a></h4><ul><li>DBV Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies S.A.'>DBVT</a>) initiates a <a href=\"https://seekingalpha.com/pr/17465921-dbv-technologies-announces-launch-proposed-global-offering-ordinary-shares-may-form-american\" target=\"_blank\">global offering</a> of up to 5,217,392 ordinary shares, possibly in the form of American Depositary Shares. Underwriters over-allotment will be an additional 782,608 shares. Price and terms have yet to be released.</li><li>Shares are down a fraction after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448240\" data-linked=\"DBV Tech launches equity offering\" data-tweet=\"$DBVT - DBV Tech launches equity offering https://seekingalpha.com/news/3448240-dbv-tech-launches-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448240-dbv-tech-launches-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448239\" data-ts=\"1554323072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TST\" target=\"_blank\">TST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448239-thestreetplus-5_2-on-cash-distribution-1-forminus-10-reverse-split\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TheStreet +5.2% on cash distribution, 1-for-10 reverse split</a></h4><ul>    <li>TheStreet (NASDAQ:<a href='https://seekingalpha.com/symbol/TST' title='TheStreet, Inc.'>TST</a>) has announced a <a href=\"https://seekingalpha.com/pr/17465917-thestreet-announces-distribution-stockholders\" target=\"_blank\">special cash distribution</a> in connection with approval of a 1-for-10 reverse split of common stock.</li>    <li>Shares are <font color=\"green\">up 5.2%</font> after hours.</li>    <li>The cash distribution is about $94.3M, coming to $1.77/share, funded in part by proceeds from selling its B2B business to Euromoney. Cash on hand after the distribution will be about $18.5M-$21.5M.</li>    <li>The board has approved a plan of partial liquidation of its B2B operations, and so part of the distribution will be treated as partial liquidation for tax purposes, and part as a non-dividend distribution.</li>    <li>The company is changing its fiscal and tax year to end on March 31, effective now.</li>    <li>The reverse split will be effective with the open on April 26; the shares held by a common stockholder will be automatically converted to be divided by 10, with cash in lieu of fractional shares. That move will reduce total shares outstanding from 53.3M to about 5.3M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448239\" data-linked=\"TheStreet +5.2% on cash distribution, 1-for-10 reverse split\" data-tweet=\"$TST - TheStreet +5.2% on cash distribution, 1-for-10 reverse split https://seekingalpha.com/news/3448239-thestreetplus-5_2-on-cash-distribution-1-forminus-10-reverse-split?source=tweet\" data-url=\"https://seekingalpha.com/news/3448239-thestreetplus-5_2-on-cash-distribution-1-forminus-10-reverse-split\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448238\" data-ts=\"1554323027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSPR\" target=\"_blank\">NSPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448238-inspiremd-down-22-after-hours-on-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">InspireMD down 22% after hours on stock offering</a></h4><ul><li>InspireMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a>) slumps <font color=\"red\">22%</font> after hours in reaction to its planned public <a href=\"https://seekingalpha.com/pr/17465925-inspiremd-inc-announces-proposed-public-offering-common-stock\" target=\"_blank\">stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448238\" data-linked=\"InspireMD down 22% after hours on stock offering\" data-tweet=\"$NSPR - InspireMD down 22% after hours on stock offering https://seekingalpha.com/news/3448238-inspiremd-down-22-after-hours-on-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448238-inspiremd-down-22-after-hours-on-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448229\" data-ts=\"1554322202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASND\" target=\"_blank\">ASND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448229-ascendis-pharma-reports-fy-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascendis Pharma reports FY results</a></h4><ul><li>Ascendis Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ASND' title='Ascendis Pharma A/S'>ASND</a>): FY GAAP EPS of -\u20ac3.17.</li><li>Revenue of \u20ac10.58M (+591.5% Y/Y)</li><li>Shares <font color=\"green\">+2.01%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17465881-ascendis-pharma-s-reports-full-year-2018-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3448229\" data-linked=\"Ascendis Pharma reports FY results\" data-tweet=\"$ASND - Ascendis Pharma reports FY results https://seekingalpha.com/news/3448229-ascendis-pharma-reports-fy-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3448229-ascendis-pharma-reports-fy-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448228\" data-ts=\"1554322122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVEO\" target=\"_blank\">AVEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448228-aveo-pharma-down-23-after-hours-on-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AVEO Pharma down 23% after hours on stock offering</a></h4><ul><li>AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) slumps <font color=\"red\">23%</font> after hours in response to its planned <a href=\"https://seekingalpha.com/pr/17465884-aveo-pharmaceuticals-inc-announces-proposed-public-offering\" target=\"_blank\">stock offering</a>. Price, volume and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448228\" data-linked=\"AVEO Pharma down 23% after hours on stock offering\" data-tweet=\"$AVEO - AVEO Pharma down 23% after hours on stock offering https://seekingalpha.com/news/3448228-aveo-pharma-down-23-after-hours-on-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448228-aveo-pharma-down-23-after-hours-on-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448226\" data-ts=\"1554322003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGMO\" target=\"_blank\">SGMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448226-sangamo-down-5-after-hours-on-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sangamo down 5% after hours on equity offering</a></h4><ul><li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) slips <font color=\"red\">5%</font> after hours in reaction to its planned <a href=\"https://seekingalpha.com/pr/17465896-sangamo-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448226\" data-linked=\"Sangamo down 5% after hours on equity offering\" data-tweet=\"$SGMO - Sangamo down 5% after hours on equity offering https://seekingalpha.com/news/3448226-sangamo-down-5-after-hours-on-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3448226-sangamo-down-5-after-hours-on-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448221\" data-ts=\"1554321449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448221-zayoplus-4-on-report-sale-process-moving-multiple-bidders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zayo +4% on report sale process moving with multiple bidders</a></h4><ul>   <li>Zayo Group (<a href=\"http://seekingalpha.com/symbol/ZAYO\" target=\"_blank\">ZAYO</a> <font color=\"green\">+4.1%</font>) has legged higher this afternoon after a StreetInsider report that a sale of the company is <a href=\"https://www.streetinsider.com/Hot+M+and+A/Zayo+%28ZAYO%29+Sale+Moving+Forward%2C+Final+Bids+Due+Next+Week+-+Sources/15336139.html\" target=\"_blank\">moving forward</a> with multiple bidders still engaged.</li>    <li>At least four are in the running for Zayo, with offers of $32-$34/share for the company as a whole, according to the report.</li>    <li>Bids for at least part of Zayo are due next Friday.</li>  <li><b>Updated 4:06 p.m.:</b> Bloomberg points to a dealReporter item saying Zayo is in advanced talks with an infrastructure consortium that includes <a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a>, Digital Colony, and Omers. Shares closed at $29.30 today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448221\" data-linked=\"Zayo +4% on report sale process moving with multiple bidders\" data-tweet=\"$EQT $ZAYO - Zayo +4% on report sale process moving with multiple bidders https://seekingalpha.com/news/3448221-zayoplus-4-on-report-sale-process-moving-multiple-bidders?source=tweet\" data-url=\"https://seekingalpha.com/news/3448221-zayoplus-4-on-report-sale-process-moving-multiple-bidders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448219\" data-ts=\"1554320682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCFP\" target=\"_blank\">PCFP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448219-apotheca-to-change-tickers-tomorrow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apotheca to change tickers tomorrow</a></h4><ul><li>Citing the need for a ticker that reflects its connection to the cannabidiol &#40;CBD&#41; industry, Apotheca Biosciences (<a href='https://seekingalpha.com/symbol/PCFP' title='Apotheca Biosciences, Inc.'>OTCPK:PCFP</a> <font color=\"green\">+18.8%</font>) will change its ticker to \"CBDC\" effective tomorrow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448219\" data-linked=\"Apotheca to change tickers tomorrow\" data-tweet=\"$PCFP $CBDC - Apotheca to change tickers tomorrow https://seekingalpha.com/news/3448219-apotheca-to-change-tickers-tomorrow?source=tweet\" data-url=\"https://seekingalpha.com/news/3448219-apotheca-to-change-tickers-tomorrow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448217\" data-ts=\"1554320257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448217-crypto-rally-continues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crypto rally continues</a></h4><ul><li>It's now day two of the great crypto bounce of 2019, with Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) <font color=\"green\">higher by another 5.25%</font> to $5,164. That's <font color=\"green\">up about 25%</font> in two sessions, and the big cheese's highest price since late November.</li><li>Ether (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>), Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>), Bitcoin Cash (<a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a>), and Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>) are making even bigger moves, with BCH <font color=\"green\">up 40%</font> just today, and Litecoin <font color=\"green\">up 23%</font>.</li><li><a href=\"https://twitter.com/novogratz/status/1113525895820730370\" target=\"_blank\">Mike Novogratz chimes in</a>, arguging that Litecoin has gotten far too pricey in relation to Bitcoin. He'd sell LTC to buy BTC.</li><li><a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a> <font color=\"green\">+12.3%</font> on the session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448217\" data-linked=\"Crypto rally continues\" data-tweet=\"$GBTC $BTC-USD $ETH-USD - Crypto rally continues https://seekingalpha.com/news/3448217-crypto-rally-continues?source=tweet\" data-url=\"https://seekingalpha.com/news/3448217-crypto-rally-continues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448215\" data-ts=\"1554320217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448215-amazon-wants-millions-for-roku-rival\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon wants millions for Roku rival</a></h4><ul><li>Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='green'>+0.4%</font>) is asking advertisers to commit millions to a content expansion for its streaming service, according to <a href=\"https://medium.com/cheddar/amazon-is-asking-advertisers-to-pledge-millions-of-dollars-for-new-free-streaming-services-d6846408d198\" target=\"_blank\">Cheddar sources</a>. The talks include media execs and ad agencies, and Amazon is asking for commitments that rival a large cable network.</li><li>Amazon wants to add more add-supported streaming channels to compete with Roku (<a href='https://seekingalpha.com/symbol/ROKU' title='Roku, Inc.'>ROKU</a> <font color='red'>-2.4%</font>).</li><li>Advertisers are wary of pledging big bucks without knowing what content will be included, but Amazon is still in negotiations with the content providers.</li><li>The new content is expected to arrive on Fire TVs this fall.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448215\" data-linked=\"Amazon wants millions for Roku rival\" data-tweet=\"$AMZN $ROKU - Amazon wants millions for Roku rival https://seekingalpha.com/news/3448215-amazon-wants-millions-for-roku-rival?source=tweet\" data-url=\"https://seekingalpha.com/news/3448215-amazon-wants-millions-for-roku-rival\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>117&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448213\" data-ts=\"1554319147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BURG\" target=\"_blank\">BURG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448213-chanticleer-holdings-executes-exclusive-partnership-doordash\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chanticleer Holdings executes exclusive partnership with DoorDash</a></h4><ul><li>Chanticleer Holdings (<a href='https://seekingalpha.com/symbol/BURG' title='Chanticleer Holdings, Inc.'>BURG</a> <font color='green'>+2.2%</font>) says that it has <a href=\"https://seekingalpha.com/pr/17463015-chanticleer-holdings-executes-exclusive-partnership-doordash\" target=\"_blank\">entered into an exclusive partnership</a> with DoorDash.</li><li>DoorDash is a technology company that connects customers with their favorite local and national businesses in over 3,300 cities and all 50 states across the U.S. and Canada.</li><li>Fred Glick, Chanticleer Holdings President: \u201c....This partnership is expected to help minimize costs associated with delivery while creating an entirely new revenue vertical for our brands\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3448213\" data-linked=\"Chanticleer Holdings executes exclusive partnership with DoorDash\" data-tweet=\"$BURG - Chanticleer Holdings executes exclusive partnership with DoorDash https://seekingalpha.com/news/3448213-chanticleer-holdings-executes-exclusive-partnership-doordash?source=tweet\" data-url=\"https://seekingalpha.com/news/3448213-chanticleer-holdings-executes-exclusive-partnership-doordash\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448211\" data-ts=\"1554318892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448211-caleres-and-shoe-carnival-seen-riding-high-nike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caleres and Shoe Carnival seen riding high with Nike</a></h4><ul><li>Wedbush stays <a href=\"https://www.barrons.com/articles/nike-stock-can-still-rise-51554309495\" target=\"_blank\">positive</a> on Nike (<a href='https://seekingalpha.com/symbol/NKE' title='NIKE, Inc.'>NKE</a>) on its view the company's strong product pipeline will keep growth percolating. Analyst Christopher Svezia and team keep an Outperform rating on the Swoosh.</li><li>The good run for Nike is also seen benefiting Shoe Carnival (<a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a> <font color='red'>-2.3%</font>) and Caleres (<a href='https://seekingalpha.com/symbol/CAL' title='Caleres, Inc.'>CAL</a> <font color='green'>+1.1%</font>) with same-store sales growth. Both retailers are rated at Outperform. The firm assigns a price target of $47 to SCVL to rep 48% upside potential and $36 PT on CAL to rep 44% upside.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448211\" data-linked=\"Caleres and Shoe Carnival seen riding high with Nike\" data-tweet=\"$NKE $SCVL $CAL - Caleres and Shoe Carnival seen riding high with Nike https://seekingalpha.com/news/3448211-caleres-and-shoe-carnival-seen-riding-high-nike?source=tweet\" data-url=\"https://seekingalpha.com/news/3448211-caleres-and-shoe-carnival-seen-riding-high-nike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448210\" data-ts=\"1554318684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AA\" target=\"_blank\">AA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448210-alcoa-downgraded-to-neutral-chalco-upgraded-to-buy-baml\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alcoa downgraded to Neutral, Chalco upgraded to Buy at BAML</a></h4><ul><li>BofA Merrill Lynch <a href=\"https://thefly.com/thestreet/realmoney/index.php/AAid2887941/AA-Alcoa-downgraded-to-Neutral-on-lower-prices-at-BofAMerrill\" target=\"_blank\">downgrades</a> Alcoa (<a href='https://seekingalpha.com/symbol/AA' title='Alcoa Corporation'>AA</a> <font color=\"green\">+0.2%</font>) to Neutral from Buy with a $31 price target, cut from $45, but <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/19/04/13479064/bofa-upgrades-chalco-says-aluminum-prices-have-bottomed\" target=\"_blank\">upgrades</a> Aluminum Corp. of China (<a href='https://seekingalpha.com/symbol/ACH' title='Aluminum Corporation of China Limited'>ACH</a> <font color=\"green\">+7.3%</font>) to Buy from Neutral.</li><li>BAML analyst Timna Tanners sees limited free cash flow payments by Alcoa to upstream AWAC joint venture partner Alumina Ltd., potential excess alumina and bauxite supply, and potential price risks from a restart of the Alunorte refinery.</li><li>The firm cuts its aluminum price forecast by 5%-6% for 2019 and 2020, and believes Chinese exports will cap potential price gains, benefiting ACH, whose shares have been under pressure for the past 12 months and now fully reflect balance sheet concerns.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448210\" data-linked=\"Alcoa downgraded to Neutral, Chalco upgraded to Buy at BAML\" data-tweet=\"$AA $ACH - Alcoa downgraded to Neutral, Chalco upgraded to Buy at BAML https://seekingalpha.com/news/3448210-alcoa-downgraded-to-neutral-chalco-upgraded-to-buy-baml?source=tweet\" data-url=\"https://seekingalpha.com/news/3448210-alcoa-downgraded-to-neutral-chalco-upgraded-to-buy-baml\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448208\" data-ts=\"1554318004\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOT\" target=\"_blank\">RIOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448208-amd-qtt-and-veri-among-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD, QTT and VERI among tech movers</a></h4><ul><li><strong>Gainers: </strong>Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"green\">+14%</font>. Veritone (NASDAQ:<a href='https://seekingalpha.com/symbol/VERI' title='Veritone, Inc.'>VERI</a>) <font color=\"green\">+14%</font>. AstroNova (NASDAQ:<a href='https://seekingalpha.com/symbol/ALOT' title='AstroNova, Inc.'>ALOT</a>) <font color=\"green\">+11%</font>. Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) <font color=\"green\">+9%</font>. VivoPower International (NASDAQ:<a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a>) <font color=\"green\">+9%</font>.</li> <li><strong>Losers: </strong>Fusion Connect (NASDAQ:<a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a>) <font color=\"red\">-82%</font>. Phunware (NASDAQ:<a href='https://seekingalpha.com/symbol/PHUN' title='Phunware Inc.'>PHUN</a>) <font color=\"red\">-57%</font>. Super League Gaming (NASDAQ:<a href='https://seekingalpha.com/symbol/SLGG' title='Super League Gaming, Inc.'>SLGG</a>) <font color=\"red\">-9%</font>. Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a>) <font color=\"red\">-8%</font>. RigNet (NASDAQ:<a href='https://seekingalpha.com/symbol/RNET' title='RigNet, Inc.'>RNET</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448208\" data-linked=\"AMD, QTT and VERI among tech movers\" data-tweet=\"$RIOT $VERI $ALOT - AMD, QTT and VERI among tech movers https://seekingalpha.com/news/3448208-amd-qtt-and-veri-among-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448208-amd-qtt-and-veri-among-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448205\" data-ts=\"1554316875\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APC\" target=\"_blank\">APC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448205-colorado-senate-passes-oil-and-gas-overhaul-bill-headed-to-governor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Colorado senate passes oil and gas overhaul bill, headed to governor</a></h4><ul><li>A sweeping overhaul of Colorado's oil and natural gas laws that gives local governments more power to regulate drilling is <a href=\"https://www.denverpost.com/2019/04/03/colorado-oil-gas-bill-senate-approves-amendments/\" target=\"_blank\">headed to the governor's desk</a> after the state senate today approved amendments made in the House.</li><li>The Senate vote was 19-16, strictly on party lines with all Democrats voting yes and all Republicans voting no.</li><li>The shale boom has raised Colorado to the no. 5 oil producer in the U.S., ahead of Alaska and California, but proximity of oil and gas development to Denver\u2019s suburbs raised concerns about health and safety after an Anadarko gas line explosion in 2017 killed two people and leveled a home.</li><li>Greater local control over regulating oil and gas operations, including the citing of drilling locations, likely will place some acreage <a href=\"https://finance.yahoo.com/news/colorado-passes-sweeping-overhaul-oil-163556171.html\" target=\"_blank\">out of reach for energy companies</a>, analysts say.</li><li>Oil and gas firms with a presence in Colorado's Denver-Julesburg Basin are mostly lower: <a href='https://seekingalpha.com/symbol/APC' title='Anadarko Petroleum Corporation'>APC</a> <font color=\"red\">-2.6%</font>, <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color=\"red\">-2.5%</font>, <a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas, Inc.'>XOG</a> <font color=\"green\">+0.3%</font>, <a href='https://seekingalpha.com/symbol/PDCE' title='PDC Energy, Inc.'>PDCE</a> <font color=\"red\">-1.6%</font>, <a href='https://seekingalpha.com/symbol/SRCI' title='SRC Energy Inc.'>SRCI</a> <font color=\"green\">+1%</font>, <a href='https://seekingalpha.com/symbol/BCEI' title='Bonanza Creek Energy, Inc.'>BCEI</a> <font color=\"red\">-2.3%</font>, <a href='https://seekingalpha.com/symbol/HPR' title='HighPoint Resources Corporation'>HPR</a> <font color=\"red\">-1.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448205\" data-linked=\"Colorado senate passes oil and gas overhaul bill, headed to governor\" data-tweet=\"$APC $NBL $XOG - Colorado senate passes oil and gas overhaul bill, headed to governor https://seekingalpha.com/news/3448205-colorado-senate-passes-oil-and-gas-overhaul-bill-headed-to-governor?source=tweet\" data-url=\"https://seekingalpha.com/news/3448205-colorado-senate-passes-oil-and-gas-overhaul-bill-headed-to-governor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448203\" data-ts=\"1554316558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448203-tech-gains-semis-hit-record\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech gains as semis hit record</a></h4><ul><li>The Philadelphia Semiconductor Index jumps as much as <font color=\"green\">3% </font>today to a record high on rising hopes of a US-China trade deal and bullish reports on <a href=\"https://seekingalpha.com/news/3448014-amd-will-see-significant-h2-sales-boost-digitimes\" target=\"_blank\">AMD</a>, <a href=\"https://seekingalpha.com/news/3448039-nomura-new-buy-intels-eps-potential\" target=\"_blank\">Intel</a>, and <a href=\"https://seekingalpha.com/news/3448024-tsmcs-7nm-orders-grow-smartphone-demand\" target=\"_blank\">TSMC</a>.</li><li>The tech sector (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) is <font color=\"green\">up 0.8%</font>, the S&amp;P 500 IT gains <font color=\"green\">0.8%</font>, and the tech-heavy Nasdaq 100 is <font color=\"green\">up 0.6%</font>.</li><li>Related semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3448203\" data-linked=\"Tech gains as semis hit record\" data-tweet=\"$XLK $SOXL $SOXX - Tech gains as semis hit record https://seekingalpha.com/news/3448203-tech-gains-semis-hit-record?source=tweet\" data-url=\"https://seekingalpha.com/news/3448203-tech-gains-semis-hit-record\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448201\" data-ts=\"1554315836\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMT\" target=\"_blank\">KMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448201-kennametal-upgraded-barclays-says-fcf-margins-to-double-over-2minus-3-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kennametal upgraded at Barclays, says FCF margins to double over 2-3 years</a></h4><ul><li>Kennametal (<a href='https://seekingalpha.com/symbol/KMT' title='Kennametal Inc.'>KMT</a> <font color='green'>+1.9%</font>) moves higher after Barclays <a href=\"https://thefly.com/thestreet/realmoney/index.php/KMTid2887897/KMT-Barclays-upgrades-Kennametal-to-Overweight-sees-sales-near-trough\" target=\"_blank\">upgrades</a> shares to Overweight from Equal Weight with a $44 price target, raised from $38, seeing free cash flow margins doubling over the next 2-3 years.</li><li>KMT's sales have been slowing for 18 months but that it is now \"near trough,\" says Barclays analyst Julian Mitchell, also noting the stock is trading at a 17% discount on price-to-earnings, relative to the comparable point of its prior upturns.</li><li>Mitchell also thinks KMT is executing well on its modernization program, \"for which investors appear to be giving no credit.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3448201\" data-linked=\"Kennametal upgraded at Barclays, says FCF margins to double over 2-3 years\" data-tweet=\"$KMT - Kennametal upgraded at Barclays, says FCF margins to double over 2-3 years https://seekingalpha.com/news/3448201-kennametal-upgraded-barclays-says-fcf-margins-to-double-over-2minus-3-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3448201-kennametal-upgraded-barclays-says-fcf-margins-to-double-over-2minus-3-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448199\" data-ts=\"1554315332\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAK\" target=\"_blank\">BAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448199-braskemminus-2-after-request-to-freeze-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Braskem -2% after request to freeze some assets</a></h4><ul><li>Braskem (<a href='https://seekingalpha.com/symbol/BAK' title='Braskem S.A.'>BAK</a> <font color='red'>-2.2%</font>) shares are on pace for their worst two-day slump since November  following news that authorities in Brazil's Alagoas state requested the <a href=\"https://www.sec.gov/Archives/edgar/data/1071438/000129281419001104/bak20190402_6k1.htm\" target=\"_blank\">freezing of ~6.7B reais of the company's  assets</a> in the wake of the recent incident at the chlor-alkali plant.</li><li>Analysts from the Planner brokerage say the decision is a  headwind for BAK and already was reflected in the stock's poor performance  yesterday.</li><li>Today's trading volume is well more than double the stock's 20-day average.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448199\" data-linked=\"Braskem -2% after request to freeze some assets\" data-tweet=\"$BAK - Braskem -2% after request to freeze some assets https://seekingalpha.com/news/3448199-braskemminus-2-after-request-to-freeze-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3448199-braskemminus-2-after-request-to-freeze-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448220\" data-ts=\"1554314546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPR\" target=\"_blank\">SPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448220-spirit-aerosystemsminus-5-cowen-cuts-on-risk-from-737-max-groundings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit AeroSystems -5% as Cowen cuts on risk from 737 MAX groundings</a></h4><ul><li>Spirit Aerosystems (<a href='https://seekingalpha.com/symbol/SPR' title='Spirit AeroSystems Holdings, Inc.'>SPR</a> <font color=\"red\">-4.9%</font>) sinks to its lowest level since late January after Cowen <a href=\"https://thefly.com/thestreet/realmoney/index.php/SPR;BAid2887972/SPR;BA-Spirit-AeroSystems-downgraded-to-Market-Perform-from-Outperform-at-Cowen-\" target=\"_blank\">downgrades</a> shares to Market Perform from Outperform with a $95 price target.</li><li>Cowen's Cai von Rumohr says increased potential for a rate adjustment for the Boeing 737 MAX aircraft likely will offset the expected upside from the Asco acquisition.</li><li>With a lower 2020 cash flow yield than Boeing and less pricing power, the analyst says SPR looks fairly priced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448220\" data-linked=\"Spirit AeroSystems -5% as Cowen cuts on risk from 737 MAX groundings\" data-tweet=\"$SPR - Spirit AeroSystems -5% as Cowen cuts on risk from 737 MAX groundings https://seekingalpha.com/news/3448220-spirit-aerosystemsminus-5-cowen-cuts-on-risk-from-737-max-groundings?source=tweet\" data-url=\"https://seekingalpha.com/news/3448220-spirit-aerosystemsminus-5-cowen-cuts-on-risk-from-737-max-groundings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448195\" data-ts=\"1554314464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448195-amyris-and-key-energy-services-among-energy-materials-gainers-tengasco-and-matador-resources\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris and Key Energy Services among Energy/Materials gainers; Tengasco and Matador Resources among losers</a></h4><ul><li><b>Gainers: </b>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+15%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+13%</font>. ZK International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"green\">+11%</font>. SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"green\">+11%</font>. Pioneer Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services Corp.'>PES</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Tengasco (NYSEMKT:<a href='https://seekingalpha.com/symbol/TGC' title='Tengasco, Inc.'>TGC</a>) <font color=\"red\">-8%</font>. Matador Resources (NYSE:<a href='https://seekingalpha.com/symbol/MTDR' title='Matador Resources Company'>MTDR</a>) <font color=\"red\">-8%</font>. SM Energy (NYSE:<a href='https://seekingalpha.com/symbol/SM' title='SM Energy Company'>SM</a>) <font color=\"red\">-6%</font>. Sanchez Midstream Partners (NYSEMKT:<a href='https://seekingalpha.com/symbol/SNMP' title='Sanchez Midstream Partners LP'>SNMP</a>) <font color=\"red\">-6%</font>. Mexco Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448195\" data-linked=\"Amyris and Key Energy Services among Energy/Materials gainers; Tengasco and Matador Resources among losers\" data-tweet=\"$AMRS $KEG $ZKIN - Amyris and Key Energy Services among Energy/Materials gainers; Tengasco and Matador Resources among losers https://seekingalpha.com/news/3448195-amyris-and-key-energy-services-among-energy-materials-gainers-tengasco-and-matador-resources?source=tweet\" data-url=\"https://seekingalpha.com/news/3448195-amyris-and-key-energy-services-among-energy-materials-gainers-tengasco-and-matador-resources\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448192\" data-ts=\"1554313791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KURA\" target=\"_blank\">KURA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448192-kura-up-1-on-tipifarnib-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kura up 1% on tipifarnib data</a></h4><ul><li>Kura Oncology (<a href='https://seekingalpha.com/symbol/KURA' title='Kura Oncology, Inc.'>KURA</a> <font color=\"green\">+1.3%</font>) is up on below-average volume following the <a href=\"https://seekingalpha.com/pr/17464262-kura-oncology-identifies-farnesylated-proteins-associated-cxcl12-expression-potential\" target=\"_blank\">presentation </a>of new data supporting the mechanism of action of lead drug tipifarnib at AACR in Atlanta.</li><li>Tipifarnib is inhibits an enzyme called farnesyltransferase which plays a key role in cell cycle progression. Since cancer is defined as unregulated cell proliferation, inhibiting the enzyme would theoretically inhibit cancer progression.</li><li>The company is currently conducting a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02383927?term=kura+oncology&amp;rank=2\" target=\"_blank\">Phase 2 clinical trial</a> evaluating tipifarnib in patients with HRAS mutation-positive head and neck cancer. HRAS is an exclusively farnesylated oncogene (considered to cause cancer).</li><li>In tumor models and cancer patients, tipifarnib has shown to downregulate the production of a signaling protein called CXCL12.</li><li>The data presented at AACR suggests that gene expression of certain exclusively farnesylated proteins is strongly associated with CXCL12 expression in bone marrow cells, supporting the rationale of farnesyl transferase inhibition. It also supports the rationale of using CXCL12 as a biomarker for potential clinical benefit.</li><li>Piper's Tyler Van Buren is an early cheerleader, convinced that tipifarnib will be a winner. He rates the stock Overweight with a $25 (33% upside) price target.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448192\" data-linked=\"Kura up 1% on tipifarnib data\" data-tweet=\"$KURA - Kura up 1% on tipifarnib data https://seekingalpha.com/news/3448192-kura-up-1-on-tipifarnib-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3448192-kura-up-1-on-tipifarnib-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448190\" data-ts=\"1554313382\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JRVR\" target=\"_blank\">JRVR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448190-uber-insurer-james-river-group-drops-after-rating-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Uber insurer James River Group drops after rating cut</a></h4><ul><li>James River Group (NASDAQ:<a href='https://seekingalpha.com/symbol/JRVR' title='James River Group Holdings, Ltd.'>JRVR</a>)<font color=\"red\"> sinks 4.9%</font>, the biggest intraday decline at least four months, after Compass Point analyst Bijan Moazami writes that there are \"too many concerns\" to save the insurer's buy rating.</li><li>Cut to neutral; price target to $39 from $47.</li><li>Its dependence on its largest account, Uber, which \"will likely go away\" as of March 1, 2020 figures prominently, Moazami writes.</li></ul><ol><li>Uber accounts for almost 45% of gross written premiums in James River Group's excess &amp; surplus lines segment.</li><li>Also \"uncomfortably large dependence\" on BB&amp;T as a producer and \"poor reputation\" of Atlas General Insurance, which is in a fronting pact with James River, present concerns.</li></ol><ul><li><a href=\"https://seekingalpha.com/symbol/JRVR/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448190\" data-linked=\"Uber insurer James River Group drops after rating cut\" data-tweet=\"$JRVR - Uber insurer James River Group drops after rating cut https://seekingalpha.com/news/3448190-uber-insurer-james-river-group-drops-after-rating-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3448190-uber-insurer-james-river-group-drops-after-rating-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448189\" data-ts=\"1554312981\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTXS\" target=\"_blank\">CTXS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448189-citrix-hires-goldman-for-potential-sale-nyp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citrix hires Goldman for potential sale - NYP</a></h4><ul><li>Citrix Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CTXS' title='Citrix Systems, Inc.'>CTXS</a>) pops <font color=\"green\">5.4%</font> after the <a href=\"https://nypost.com/2019/04/03/software-giant-citrix-hires-goldman-to-explore-sale-after-singer-push/\" target=\"_blank\">New York Post reports</a> the company has hired Goldman Sachs for a potential sale.</li><li>Citrix wants a buyer willing to pay more than $15B.</li><li>Goldman is reaching out to logical targets like PE firm Vista Equity Partners.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448189\" data-linked=\"Citrix hires Goldman for potential sale - NYP\" data-tweet=\"$CTXS - Citrix hires Goldman for potential sale - NYP https://seekingalpha.com/news/3448189-citrix-hires-goldman-for-potential-sale-nyp?source=tweet\" data-url=\"https://seekingalpha.com/news/3448189-citrix-hires-goldman-for-potential-sale-nyp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448185\" data-ts=\"1554312671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448185-bloomberg-facebook-user-records-stored-publicly-on-aws-servers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Facebook user records stored publicly on AWS servers</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"green\">+0.9%</font>) has trimmed gains after Bloomberg headlines noting millions of user records were found to be stored publicly on Amazon Web Services servers.</li>    <li>Shares were <font color=\"green\">up as much as 2.2%</font> before the reports took some air out.</li>    <li>Facebook worked with Amazon to take the data down, Bloomberg says.</li><li><strong>Updated:</strong> The <a href=\"https://www.bloomberg.com/news/articles/2019-04-03/millions-of-facebook-records-found-on-amazon-cloud-servers-ju1hde0w\" target=\"_blank\">report</a> says researchers at UpGuard found the information hiding on plain sight on the cloud servers.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448185\" data-linked=\"Bloomberg: Facebook user records stored publicly on AWS servers\" data-tweet=\"$FB - Bloomberg: Facebook user records stored publicly on AWS servers https://seekingalpha.com/news/3448185-bloomberg-facebook-user-records-stored-publicly-on-aws-servers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448185-bloomberg-facebook-user-records-stored-publicly-on-aws-servers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448182\" data-ts=\"1554312233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OESX\" target=\"_blank\">OESX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448182-orion-secures-additional-35m-led-lighting-installation-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orion secures additional $35M LED lighting installation contract</a></h4><ul><li>Orion Energy Systems (<a href='https://seekingalpha.com/symbol/OESX' title='Orion Energy Systems, Inc'>OESX</a> <font color=\"green\">+16.7%</font>) <a href=\"https://seekingalpha.com/pr/17464915-orion-secures-additional-35-million-led-lighting-installation-contract\" target=\"_blank\">announced</a> it has expanded the retrofit of a major national account customer\u2019s lighting systems with Orion\u2019s state-of-the-art LED lighting and wireless IoT enabled control solutions at additional locations nationwide.</li><li>Orion anticipates additional revenue of $35M under the contract, which is dependent on the customer's issuance of purchase orders.</li><li>A significant portion of the installations are expected to be completed in FY20 first quarter ending June 30, 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448182\" data-linked=\"Orion secures additional $35M LED lighting installation contract\" data-tweet=\"$OESX - Orion secures additional $35M LED lighting installation contract https://seekingalpha.com/news/3448182-orion-secures-additional-35m-led-lighting-installation-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3448182-orion-secures-additional-35m-led-lighting-installation-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448181\" data-ts=\"1554311980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTCH\" target=\"_blank\">MTCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448181-match-bull-sees-sustainable-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Match bull sees &quot;sustainable&quot; growth</a></h4><ul><li>Jefferies says Match Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MTCH' title='Match Group, Inc.'>MTCH</a>) should deliver \"sustainable\" mid to high teen growth for revenue and high 30% for margins.</li><li>Though it thinks Match can't maintain last year's 30% growth, Jefferies sees a \"robust\" international opportunity as the company throws more weight into under-penetrated regions like India and Japan.</li><li>Rating maintained at Buy with a $64 PT.</li><li>Match shares are <font color=\"green\">up 1.6%</font> to $57.57.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448181\" data-linked=\"Match bull sees &quot;sustainable&quot; growth\" data-tweet=\"$MTCH - Match bull sees &quot;sustainable&quot; growth https://seekingalpha.com/news/3448181-match-bull-sees-sustainable-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3448181-match-bull-sees-sustainable-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448177\" data-ts=\"1554311190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448177-lm-funding-america-leads-financial-gainers-irsa-inversiones-only-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LM Funding America leads financial gainers; IRSA Inversiones the only losers</a></h4><ul><li><b>Gainers:</b> LM Funding America (NASDAQ:<a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a>) <font color=\"green\">+10%</font>. MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"green\">+10%</font>. Ocwen Financial (NYSE:<a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a>) <font color=\"green\">+7%</font>. Nicholas Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/NICK' title='Nicholas Financial, Inc.'>NICK</a>) <font color=\"green\">+7%</font>. Jupai Holdings (NYSE:<a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings Limited'>JP</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> IRSA Inversiones y Representaciones Sociedad Anonima (NYSE:<a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones y Representaciones Sociedad Anónima'>IRS</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448177\" data-linked=\"LM Funding America leads financial gainers; IRSA Inversiones the only losers\" data-tweet=\"$LMFA $MGI $OCN - LM Funding America leads financial gainers; IRSA Inversiones the only losers https://seekingalpha.com/news/3448177-lm-funding-america-leads-financial-gainers-irsa-inversiones-only-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448177-lm-funding-america-leads-financial-gainers-irsa-inversiones-only-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448173\" data-ts=\"1554310845\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448173-ocean-power-technologies-leads-industrial-gainers-forterra-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power Technologies leads industrial gainers; Forterra leads the losers</a></h4><ul><li><b>Gainers: </b>Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"green\">+196%</font>. DMC Global (NASDAQ:<a href='https://seekingalpha.com/symbol/BOOM' title='DMC Global Inc.'>BOOM</a>) <font color=\"green\">+19%</font>. Fuel Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a>) <font color=\"green\">+17%</font>. Jason Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/JASN' title='Jason Industries, Inc.'>JASN</a>) <font color=\"green\">+6%</font>. LSI Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LYTS' title='LSI Industries Inc.'>LYTS</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Forterra (NASDAQ:<a href='https://seekingalpha.com/symbol/FRTA' title='Forterra, Inc.'>FRTA</a>) <font color=\"red\">-7%</font>. Legacy Housing (NASDAQ:<a href='https://seekingalpha.com/symbol/LEGH' title='Legacy Housing Corporation'>LEGH</a>) <font color=\"red\">-7%</font>. Intelligent Systems (NYSEMKT:<a href='https://seekingalpha.com/symbol/INS' title='Intelligent Systems Corporation'>INS</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448173\" data-linked=\"Ocean Power Technologies leads industrial gainers; Forterra leads the losers\" data-tweet=\"$OPTT $BOOM $FTEK - Ocean Power Technologies leads industrial gainers; Forterra leads the losers https://seekingalpha.com/news/3448173-ocean-power-technologies-leads-industrial-gainers-forterra-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448173-ocean-power-technologies-leads-industrial-gainers-forterra-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448170\" data-ts=\"1554310645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRSP\" target=\"_blank\">PRSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448170-perspectaplus-3_6-on-darpa-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Perspecta +3.6% on DARPA contract</a></h4><ul><li>Perspecta's (NYSE:<a href='https://seekingalpha.com/symbol/PRSP' title='Perspecta Inc.'>PRSP</a>) research arm receives a $4.8M contract option for the second phase of the Defense Advanced Research Projects Agency's information security program.</li><li>Perspecta shares are <font color=\"green\">up 3.6%</font> to $21.58.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448170\" data-linked=\"Perspecta +3.6% on DARPA contract\" data-tweet=\"$PRSP - Perspecta +3.6% on DARPA contract https://seekingalpha.com/news/3448170-perspectaplus-3_6-on-darpa-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3448170-perspectaplus-3_6-on-darpa-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448164\" data-ts=\"1554310035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448164-microcaps-mostly-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps mostly among midday movers</a></h4><ul><li><strong>Gainers: </strong>Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"green\">+176%</font>. Netshoes (Cayman) (NYSE:<a href='https://seekingalpha.com/symbol/NETS' title='Netshoes &#40;Cayman&#41; Limited'>NETS</a>) <font color=\"green\">+23%</font>. Evogene (NASDAQ:<a href='https://seekingalpha.com/symbol/EVGN' title='Evogene Ltd.'>EVGN</a>) <font color=\"green\">+22%</font>. Zynerba Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals, Inc.'>ZYNE</a>) <font color=\"green\">+21%</font>. DMC Global (NASDAQ:<a href='https://seekingalpha.com/symbol/BOOM' title='DMC Global Inc.'>BOOM</a>) <font color=\"green\">+19%</font>. Fuel Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a>) <font color=\"green\">+18%</font>. VivoPower International (NASDAQ:<a href='https://seekingalpha.com/symbol/VVPR' title='VivoPower International PLC'>VVPR</a>) <font color=\"green\">+15%</font>. Veritone (NASDAQ:<a href='https://seekingalpha.com/symbol/VERI' title='Veritone, Inc.'>VERI</a>) <font color=\"green\">+16%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+16%</font>. China Eastern Airlines Corporation (NYSE:<a href='https://seekingalpha.com/symbol/CEA' title='China Eastern Airlines Corporation Limited'>CEA</a>) <font color=\"green\">+16%</font>.</li> <li><strong>Losers: </strong>Fusion Connect (NASDAQ:<a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a>) <font color=\"red\">-81%</font>. Obalon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a>) <font color=\"red\">-41%</font>. Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a>) <font color=\"red\">-30%</font>. Pulmatrix (NASDAQ:<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a>) <font color=\"red\">-14%</font>. SG Blocks (NASDAQ:<a href='https://seekingalpha.com/symbol/SGBX' title='SG Blocks, Inc.'>SGBX</a>) <font color=\"red\">-10%</font>. PhaseBio Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/PHAS' title='PhaseBio Pharmaceuticals, Inc.'>PHAS</a>) <font color=\"red\">-10%</font>. Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"red\">-9%</font>. Neon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NTGN' title='Neon Therapeutics, Inc.'>NTGN</a>) <font color=\"red\">-9%</font>. Legacy Housing (NASDAQ:<a href='https://seekingalpha.com/symbol/LEGH' title='Legacy Housing Corporation'>LEGH</a>) <font color=\"red\">-8%</font>. Tengasco (NYSEMKT:<a href='https://seekingalpha.com/symbol/TGC' title='Tengasco, Inc.'>TGC</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448164\" data-linked=\"Microcaps mostly among midday movers\" data-tweet=\"$OPTT $NETS $EVGN - Microcaps mostly among midday movers https://seekingalpha.com/news/3448164-microcaps-mostly-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448164-microcaps-mostly-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448158\" data-ts=\"1554309348\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448158-nielsen-jumps-6_2-on-word-p-e-sale-is-close\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen jumps 6.2% on word P-E sale is close</a></h4><ul>   <li>After hanging on steady 1% gains most of today, Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings plc'>NLSN</a>) has <font color=\"green\">spiked 6.2%</font> amid chatter that it's close to a deal to sell to private equity.</li>    <li>That would come via a final-round bid said to be in the low-$30 range for shares, which are currently up to $25.59.</li><li>A squeeze may be on after some heavy short-sale volume.</li><li><a href=\"https://www.streetinsider.com/Hot+M+and+A/Nielsen+%28NLSN%29+Received+Final+Round+Bid+in+Low-%2430s%2C+PE+Deal+Seen+as+Close+-+Source/15335684.html\" target=\"_blank\">StreetInsider says</a> two P-E firms submitted bids.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446498-nielsen-minus-9_5-percent-amid-weaker-case-sale\" target=\"_blank\">Nielsen -9.5% amid weaker case for sale</a> (Mar. 28 2019)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446270-nielsen-minus-10-percent-report-blackstones-auction-company\" target=\"_blank\">Nielsen -10% on report Blackstone's out of auction for company</a> (Mar. 27 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448158\" data-linked=\"Nielsen jumps 6.2% on word P-E sale is close\" data-tweet=\"$NLSN - Nielsen jumps 6.2% on word P-E sale is close https://seekingalpha.com/news/3448158-nielsen-jumps-6_2-on-word-p-e-sale-is-close?source=tweet\" data-url=\"https://seekingalpha.com/news/3448158-nielsen-jumps-6_2-on-word-p-e-sale-is-close\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448156\" data-ts=\"1554309049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TME\" target=\"_blank\">TME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448156-report-china-probes-tencent-music-over-antitrust-concern\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: China probes Tencent Music over antitrust concern</a></h4><ul>    <li>Tencent Music Entertainment (<a href=\"http://seekingalpha.com/symbol/TME\" target=\"_blank\">TME</a> <font color=\"green\">+1.9%</font>) is under investigation regarding potential market dominance in China, Capitol Forum reports.</li>    <li>That news caused a quick loss of nearly all of today's gains, though shares quickly recovered in part. They're still off their peak of $19.42.</li>    <li>China's State Administration for Market Regulation is examining antitrust issues, according to the report.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448156\" data-linked=\"Report: China probes Tencent Music over antitrust concern\" data-tweet=\"$TME - Report: China probes Tencent Music over antitrust concern https://seekingalpha.com/news/3448156-report-china-probes-tencent-music-over-antitrust-concern?source=tweet\" data-url=\"https://seekingalpha.com/news/3448156-report-china-probes-tencent-music-over-antitrust-concern\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448148\" data-ts=\"1554307927\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMC\" target=\"_blank\">CMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448148-commercial-metalsplus-5-credit-suisse-rates-top-pick-among-steel-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Commercial Metals +5% as Credit Suisse rates top pick among steel stocks</a></h4><ul><li>Commercial Metals (<a href='https://seekingalpha.com/symbol/CMC' title='Commercial Metals Company'>CMC</a> <font color='green'>+5.2%</font>) climbs to three-month highs after Credit Suisse raises its FY 2020 estimates following meetings with company management.</li><li>Credit Suisse analyst Curt Woodworth, who calls CMC a top pick across the steel universe, says he has increased confidence in H2 earnings growth and upside from unrealized synergies from the Gerdau assets.</li><li>Woodworth says CMC's major headwind in FY 2019 is clearly the FAB segment, which had negative annualized EBITDA of ~$150M in Q1, but CMC noted new FAB contracts pricing at EBITDA  margins of $60/ton, and he estimates as high as $100/ton for more recent deals.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448148\" data-linked=\"Commercial Metals +5% as Credit Suisse rates top pick among steel stocks\" data-tweet=\"$CMC - Commercial Metals +5% as Credit Suisse rates top pick among steel stocks https://seekingalpha.com/news/3448148-commercial-metalsplus-5-credit-suisse-rates-top-pick-among-steel-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3448148-commercial-metalsplus-5-credit-suisse-rates-top-pick-among-steel-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448145\" data-ts=\"1554307566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYFT\" target=\"_blank\">LYFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448145-lyft-expensive-borrow-on-short-surge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lyft &quot;most expensive&quot; borrow on short surge</a></h4><ul><li>Yesterday was the first day investors could borrow Lyft (NASDAQ:<a href='https://seekingalpha.com/symbol/LYFT' title='Lyft, Inc.'>LYFT</a>) shares to settle short sales, and the demand increased the cost of a short stake by 100%, according to <a href=\"https://www.bloomberg.com/news/articles/2019-04-03/lyft-is-now-the-most-expensive-u-s-stock-to-short-markit-says\" target=\"_blank\">IHS Markit data</a>.</li><li>In the overnight reports, 6.61M shares were reported on loan with a $455M market value.</li><li>The surge made Lyft the \"most expensive to borrow\" U.S. stock with more than $5M in balances.</li><li>Lyft shares are <font color=\"green\">up 2.8%</font> to $70.93.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448145\" data-linked=\"Lyft &quot;most expensive&quot; borrow on short surge\" data-tweet=\"$LYFT - Lyft &quot;most expensive&quot; borrow on short surge https://seekingalpha.com/news/3448145-lyft-expensive-borrow-on-short-surge?source=tweet\" data-url=\"https://seekingalpha.com/news/3448145-lyft-expensive-borrow-on-short-surge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448143\" data-ts=\"1554307296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448143-adient-and-delphi-technologies-among-consumer-gainers-dean-foods-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adient and Delphi Technologies among consumer gainers; Dean Foods leads the losers</a></h4><ul><li><b>Gainers: </b>Village Farms International (NASDAQ:<a href='https://seekingalpha.com/symbol/VFF' title='Village Farms International, Inc.'>VFF</a>) <font color=\"green\">+11%</font>. e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty, Inc.'>ELF</a>) <font color=\"green\">+10%</font>. Veoneer (NYSE:<a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a>) <font color=\"green\">+8%</font>. Delphi Technologies (NYSE:<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a>) <font color=\"green\">+7%</font>. Adient (NYSE:<a href='https://seekingalpha.com/symbol/ADNT' title='Adient plc'>ADNT</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"red\">-9%</font>. Celsius Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a>) <font color=\"red\">-6%</font>. Natural Health Trends (NASDAQ:<a href='https://seekingalpha.com/symbol/NHTC' title='Natural Health Trends Corp.'>NHTC</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448143\" data-linked=\"Adient and Delphi Technologies among consumer gainers; Dean Foods leads the losers\" data-tweet=\"$VFF $ELF $VNE - Adient and Delphi Technologies among consumer gainers; Dean Foods leads the losers https://seekingalpha.com/news/3448143-adient-and-delphi-technologies-among-consumer-gainers-dean-foods-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448143-adient-and-delphi-technologies-among-consumer-gainers-dean-foods-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448130\" data-ts=\"1554304942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKTA\" target=\"_blank\">OKTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448130-oktaplus-4-on-analyst-day-praise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Okta +4% on analyst day praise</a></h4><ul><li>Canaccord Genuity maintains a Buy rating on Okta (NASDAQ:<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a>) and raises its PT from $85 to $95 after the analyst day event.</li><li>The firm says it continues \"to construct a realistic scenario in which OKTA delivers a multi-year run of double-digit returns\" but sees the stock's valuation \"at the high end of a reasonable range\" even on \"stretch assumptions.\"</li><li>More action: Goldman Sachs reiterates a Buy rating and $94 PT saying that \"Okta\u2019s competitive advantage remains years ahead of the competition.\"</li><li>Okta shares are <font color=\"green\">up 4.2%</font> to $89.39.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448130\" data-linked=\"Okta +4% on analyst day praise\" data-tweet=\"$OKTA - Okta +4% on analyst day praise https://seekingalpha.com/news/3448130-oktaplus-4-on-analyst-day-praise?source=tweet\" data-url=\"https://seekingalpha.com/news/3448130-oktaplus-4-on-analyst-day-praise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448126\" data-ts=\"1554303872\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZYNE\" target=\"_blank\">ZYNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448126-zynerba-adds-to-up-move-shares-ahead-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynerba adds to up move; shares ahead 16%</a></h4><ul><li>Zynerba Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals, Inc.'>ZYNE</a> <font color=\"green\">+16%</font>) is up on a 4x surge in volume, adding to yesterday's <font color=\"green\">20%</font> jump after it <a href=\"https://seekingalpha.com/pr/17463679-zynerba-pharmaceuticals-present-2019-h-c-wainwright-global-life-sciences-conference\" target=\"_blank\">announced </a>an upcoming corporate presentation at H.C. Wainwright Global Health Sciences Conference on April 9.</li><li>A key looming catalyst is a <a href=\"https://seekingalpha.com/news/3426972-zynerba-pharma-38-percent\" target=\"_blank\">data readout</a> later this year from a Phase 2/3 clinical trial evaluating ZYN002, a cannabinoid transdermal gel, in patients with Fragile X syndrome.</li><li>On the working capital front, at year-end 2018, it had $59.8M in cash and equivalents while operations consumed $32.4M during the year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448126\" data-linked=\"Zynerba adds to up move; shares ahead 16%\" data-tweet=\"$ZYNE - Zynerba adds to up move; shares ahead 16% https://seekingalpha.com/news/3448126-zynerba-adds-to-up-move-shares-ahead-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3448126-zynerba-adds-to-up-move-shares-ahead-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448124\" data-ts=\"1554303700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448124-zynerba-pharmaceuticals-and-sorrento-therapeutics-among-healthcare-gainers-advaxis-and-aveo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynerba Pharmaceuticals and Sorrento Therapeutics among healthcare gainers; Advaxis and AVEO Pharmaceuticals among losers</a></h4><ul><li><b>Gainers: </b>Evogene (NASDAQ:<a href='https://seekingalpha.com/symbol/EVGN' title='Evogene Ltd.'>EVGN</a>) <font color=\"green\">+28%</font>. Zynerba Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ZYNE' title='Zynerba Pharmaceuticals, Inc.'>ZYNE</a>) <font color=\"green\">+18%</font>. InspireMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a>) <font color=\"green\">+15%</font>. Sorrento Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRNE' title='Sorrento Therapeutics, Inc.'>SRNE</a>) <font color=\"green\">+13%</font>. Aytu BioScience (NASDAQ:<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a>) <font color=\"green\">+12%</font>.</li><li><b>Losers: </b>Obalon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a>) <font color=\"red\">-39%</font>. Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a>) <font color=\"red\">-31%</font>. AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) <font color=\"red\">-13%</font>. TrovaGene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) <font color=\"red\">-9%</font>. AngioDynamics (NASDAQ:<a href='https://seekingalpha.com/symbol/ANGO' title='AngioDynamics, Inc.'>ANGO</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448124\" data-linked=\"Zynerba Pharmaceuticals and Sorrento Therapeutics among healthcare gainers; Advaxis and AVEO Pharmaceuticals among losers\" data-tweet=\"$EVGN $ZYNE $NSPR - Zynerba Pharmaceuticals and Sorrento Therapeutics among healthcare gainers; Advaxis and AVEO Pharmaceuticals among losers https://seekingalpha.com/news/3448124-zynerba-pharmaceuticals-and-sorrento-therapeutics-among-healthcare-gainers-advaxis-and-aveo?source=tweet\" data-url=\"https://seekingalpha.com/news/3448124-zynerba-pharmaceuticals-and-sorrento-therapeutics-among-healthcare-gainers-advaxis-and-aveo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448122\" data-ts=\"1554303192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGI\" target=\"_blank\">MGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448122-moneygramplus-11-on-northland-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoneyGram +11% on Northland confidence</a></h4><ul> <li>MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"green\">jumps 11.10%</font> after Northland Securities upgrades the payments firm to an Outperform rating from Market Perform on a positive view of upside potential for shares.</li> <li>\"We believe a little good news can move MGI to a 5.0x multiple,\" says Northland analyst Mike Grondahl.</li> <li>Northland assigns a Street-high price target of $5.50 on MoneyGram vs. the 52-week range of $1.59 to $8.85.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448122\" data-linked=\"MoneyGram +11% on Northland confidence\" data-tweet=\"$MGI - MoneyGram +11% on Northland confidence https://seekingalpha.com/news/3448122-moneygramplus-11-on-northland-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3448122-moneygramplus-11-on-northland-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448116\" data-ts=\"1554302698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXFO\" target=\"_blank\">EXFO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448116-on-exfos-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on EXFO&#39;s Q2 results</a></h4><ul><li>EXFO (<a href='https://seekingalpha.com/symbol/EXFO' title='EXFO Inc.'>EXFO</a> <font color=\"green\">+1.6%</font>) reported Q2 revenue growth of 14.2% Y/Y to $73.93M, with $7.5M revenue contribution from Astellia.</li><li>Test and Measurement sales $50.41M (+1.05% Y/Y); and Bookings $45.32M (-4.4% Y/Y).</li><li>Service Assurance, Systems and Services sales $23.7M (+63.9% Y/Y); and Bookings $30.95M (+73.7% Y/Y).</li><li>Bookings were at $76.1M (+16%% Y/Y), which included a $10.3M contribution from Astellia. Book-to-bill ratio of 1.03.</li><li>Q2 Gross margin <font color=\"red\">declined by 18 bps</font> to 60.7%.</li><li>Adj. EBITDA increased 252.5% Y/Y to $8.78M; and margin <font color=\"green\">improved by 803 bps </font>to 11.9%.</li><li>Cash flow from operation for the quarter was $18.69M compared to $16.25M a year ago.</li><li><strong>3Q19 Guidance:</strong> Sales $70M to $75M; and EPS -$0.04 to $0.00.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3447888-exfo-beats-0_03-beats-revenue\" target=\"_blank\">EXFO beats by $0.03, beats on revenue</a> (April 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448116\" data-linked=\"More on EXFO&#39;s Q2 results\" data-tweet=\"$EXFO - More on EXFO&#39;s Q2 results https://seekingalpha.com/news/3448116-on-exfos-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3448116-on-exfos-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448117\" data-ts=\"1554302682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACN\" target=\"_blank\">ACN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448117-accentureplus-1-on-droga5-agency-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accenture +1% on Droga5 agency acquisition</a></h4><ul><li>Accenture (NYSE:<a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a>) Interactive <a href=\"https://seekingalpha.com/pr/17465401-accenture-interactive-accelerates-mission-reinvent-agency-model-agreeing-acquire-creative\" target=\"_blank\">agrees to acquire</a> creative ad agency Droga5 for undisclosed terms.</li><li>Droga5's major clients include Under Armour, Amazon, HBO, and Covergirl.</li><li>The leadership structure of Droga5 will stay intact with David Droga as creative chairman, Sarah Thompson as global CEO, and Bill Scott as UK CEO. The creative agency has 500 employees in New York and London.</li><li>Accenture shares are <font color=\"green\">up 1%</font> to $177.09.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448117\" data-linked=\"Accenture +1% on Droga5 agency acquisition\" data-tweet=\"$ACN - Accenture +1% on Droga5 agency acquisition https://seekingalpha.com/news/3448117-accentureplus-1-on-droga5-agency-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3448117-accentureplus-1-on-droga5-agency-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448110\" data-ts=\"1554301914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IOVA\" target=\"_blank\">IOVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448110-iovance-bio-up-6-on-pipeline-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iovance Bio up 6% on pipeline update</a></h4><ul><li>Iovance Biotherapeutics (<a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color=\"green\">+6.1%</font>) is up on below-average volume after its <a href=\"https://seekingalpha.com/pr/17464727-iovance-biotherapeutics-announces-clinical-programs-update\" target=\"_blank\">update </a>on its infiltrating lymphocyte &#40;TIL&#41; clinical programs in cervical cancer and non-small cell lung cancer &#40;NSCLC&#41;.</li><li><strong>Cervical cancer</strong>: Enrollment has been increased to 59 (from 47) in a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03108495?lead=iovance&amp;rank=3\" target=\"_blank\">C-145-04</a>, evaluating lead candidate LN-145. The primary endpoint of objective response rate &#40;ORR&#41; has been modified based on prior FDA interactions with lifileucel in melanoma. The specific changes are not provided but the company says it will update investors on the registration path later this year.</li><li><strong>NSCLC</strong>: Citing advances in standard-of-care treatment, the Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03419559?lead=iovance&amp;rank=2\" target=\"_blank\">IOV-LUN-201</a> trial of LN-145, combined with AstraZeneca's (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color=\"red\">-1.5%</font>) Imfinzi (durvalumab), will be terminated and a new arm will be added to the Phase 2 <a href=\"https://clinicaltrials.gov/ct2/show/NCT03645928?lead=iovance&amp;rank=1\" target=\"_blank\">IOV-COM-202</a> solid tumor study. The new arm will allow PD-1/L1-naive NSCLC patients to receive the combination of LN-145 and Merck's (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co., Inc.'>MRK</a> <font color=\"green\">+0.3%</font>) Keytruda (pembrolizumab).</li></ul><div class=\"tiny-share-widget\" data-id=\"3448110\" data-linked=\"Iovance Bio up 6% on pipeline update\" data-tweet=\"$IOVA $AZN $MRK - Iovance Bio up 6% on pipeline update https://seekingalpha.com/news/3448110-iovance-bio-up-6-on-pipeline-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3448110-iovance-bio-up-6-on-pipeline-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448111\" data-ts=\"1554301877\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448111-crude-inventory-unexpectedly-rise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude inventory unexpectedly rise</a></h4><ul><li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>+</strong><strong>7.2</strong><strong>M</strong> barrels vs. -0.4M consensus, +2.8M last week.</li><li>Gasoline <strong>-1.8M</strong> barrels vs. -1.5M consensus, -2.9M last week.</li><li>Distillates<strong> -2.0</strong><strong>M</strong> barrels vs. -0.5M consensus, -2.1M last week.</li><li>Futures <font color=\"red\">-0.10%</font> to $62.52.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448111\" data-linked=\"Crude inventory unexpectedly rise\" data-tweet=\"$USO $OIL $UCO - Crude inventory unexpectedly rise https://seekingalpha.com/news/3448111-crude-inventory-unexpectedly-rise?source=tweet\" data-url=\"https://seekingalpha.com/news/3448111-crude-inventory-unexpectedly-rise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>63&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448108\" data-ts=\"1554301673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XPLT\" target=\"_blank\">XPLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448108-xpel-technologies-rallies-15_3-due-to-strong-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XPEL Technologies rallies 15.3% due to strong margins</a></h4><ul><li>Xpel Technologies (<a href='https://seekingalpha.com/symbol/XPLT' title='XPEL Technologies Corp.'>OTC:XPLT</a> <font color=\"green\">+15.3%</font>) reports <a href=\"https://seekingalpha.com/pr/17464807-xpel-reports-record-full-year-2018-revenue-109_9-million-growth-63_3-percent-eps-0_32\" target=\"_blank\">FY</a> revenue increased of 63.3% Y/Y to $109.9M.</li><li><p>Gross margin <font color=\"green\">increased 560 bps</font> to 30.4%; the increase was related to reductions in per unit material cost and reductions in non-product related costs.</p></li><li><p>Operating margin <font color=\"green\">increased 747 bps</font> to 10.74% &amp; EBIDTA margin <font color=\"green\">increased 648 bps</font> to 11.83%.</p></li><li><p>Cash and equivalents were $3.97M (+13.4% Y/Y).</p></li><li><p>\u201cWe look forward to the opportunities ahead and to expanding our customer base and our product and service offerings to increase our leadership position in the markets we serve.\u201d Said Ryan Pape, President and CEO of XPEL.</p></li><li>Previously: <a href=\"https://seekingalpha.com/news/3448002-xpel-technologies-reports-fy-results\" target=\"_blank\">Xpel Technologies reports FY results</a> (Apr. 03 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448108\" data-linked=\"XPEL Technologies rallies 15.3% due to strong margins\" data-tweet=\"$XPLT $XPEL - XPEL Technologies rallies 15.3% due to strong margins https://seekingalpha.com/news/3448108-xpel-technologies-rallies-15_3-due-to-strong-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3448108-xpel-technologies-rallies-15_3-due-to-strong-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448104\" data-ts=\"1554301245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448104-sinclair-broadcast-groupplus-5_3-wolfe-leapfrogs-rating-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair Broadcast Group +5.3% as Wolfe leapfrogs rating to Outperform</a></h4><ul>   <li>Sinclair Broadcast Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SBGI' title='Sinclair Broadcast Group, Inc.'>SBGI</a>) is <font color=\"green\">up 5.3%</font> after a two-notch upgrade at Wolfe Research.</li>    <li>The firm boosted its rating to Outperform from Underperform.</li>    <li>Analyst Marci Ryvicker raised the price target to $49 from $34, implying 18% further upside following today's gain so far.</li>    <li>Shares are already <font color=\"green\">up 49.9%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448104\" data-linked=\"Sinclair Broadcast Group +5.3% as Wolfe leapfrogs rating to Outperform\" data-tweet=\"$SBGI - Sinclair Broadcast Group +5.3% as Wolfe leapfrogs rating to Outperform https://seekingalpha.com/news/3448104-sinclair-broadcast-groupplus-5_3-wolfe-leapfrogs-rating-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3448104-sinclair-broadcast-groupplus-5_3-wolfe-leapfrogs-rating-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448098\" data-ts=\"1554300502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OBLN\" target=\"_blank\">OBLN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448098-obalon-to-cut-half-of-workforce-in-restructuring-shares-down-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Obalon to cut half of workforce in restructuring; shares down 21%</a></h4><ul><li>Thinly traded nano cap Obalon Therapeutics (<a href='https://seekingalpha.com/symbol/OBLN' title='Obalon Therapeutics, Inc.'>OBLN</a> <font color=\"red\">-21.2%</font>) slumps on average volume in response to its <a href=\"https://seekingalpha.com/pr/17465054-obalon-announces-restructuring-streamline-operations-and-cash-use\" target=\"_blank\">restructuring initiative</a> that will include a 50% reduction in headcount, including the elimination of its direct field sales force and reduced staff at headquarters.</li><li>Management expects Q2 operating expenses to drop ~35% after a one-time charge of ~$1M.</li><li>The company will provide more details on its new sales model and strategy next month during its Q1 earnings call.</li><li>It expects to end Q1 with about $24.7M in cash and equivalents and total debt of $20M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448098\" data-linked=\"Obalon to cut half of workforce in restructuring; shares down 21%\" data-tweet=\"$OBLN - Obalon to cut half of workforce in restructuring; shares down 21% https://seekingalpha.com/news/3448098-obalon-to-cut-half-of-workforce-in-restructuring-shares-down-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3448098-obalon-to-cut-half-of-workforce-in-restructuring-shares-down-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448091\" data-ts=\"1554299665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KALTF\" target=\"_blank\">KALTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448091-kalytera-readies-equity-offering-shares-down-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kalytera readies equity offering; shares down 15%</a></h4><ul><li>Kalytera Therapeutics (<a href='https://seekingalpha.com/symbol/KALTF' title='Kalytera Therapeutics, Inc.'>OTCQB:KALTF</a> <font color=\"red\">-14.8%</font>) has filed a preliminary short form <a href=\"https://seekingalpha.com/pr/17464983-kalytera-therapeutics-announces-short-form-prospectus-offering-units\" target=\"_blank\">prospectus </a>for a public offering of units, expected to generate between $4.5M  and $10.0M.</li><li>Each unit will consist of one share of common stock and one three-year warrant to purchase one common share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448091\" data-linked=\"Kalytera readies equity offering; shares down 15%\" data-tweet=\"$KALTF - Kalytera readies equity offering; shares down 15% https://seekingalpha.com/news/3448091-kalytera-readies-equity-offering-shares-down-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3448091-kalytera-readies-equity-offering-shares-down-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448090\" data-ts=\"1554299631\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448090-auto-parts-stocks-break-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto parts stocks break higher</a></h4><ul> <li>Another good day is shaping up for auto supplier stocks on positive U.S.-China trade news and Toyota's doubling down on the hybrid industry by opening up all its patents.</li> <li>Early gainers include Continental (<a href='https://seekingalpha.com/symbol/CTTAF' title='Continental Aktiengesellschaft'>OTCPK:CTTAF</a>) <font color=\"green\">+8.3%</font>, Veoneer (NYSE:<a href='https://seekingalpha.com/symbol/VNE' title='Veoneer, Inc.'>VNE</a>) <font color=\"green\">+8.2%</font>, Adient (NYSE:<a href='https://seekingalpha.com/symbol/ADNT' title='Adient plc'>ADNT</a>) <font color=\"green\">+3.6%</font>, Autoliv (NYSE:<a href='https://seekingalpha.com/symbol/ALV' title='Autoliv, Inc.'>ALV</a>) <font color=\"green\">+3.3%, </font>Cooper-Standard Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a>) <font color=\"green\">+3.2%</font>, Visteon (NASDAQ:<a href='https://seekingalpha.com/symbol/VC' title='Visteon Corporation'>VC</a>) <font color=\"green\">+2.8%</font>, Spartan Motors (NASDAQ:<a href='https://seekingalpha.com/symbol/SPAR' title='Spartan Motors, Inc.'>SPAR</a>) <font color=\"green\">+2.6%</font>, Delphi Technologies (NYSE:<a href='https://seekingalpha.com/symbol/DLPH' title='Delphi Technologies PLC'>DLPH</a>) <font color=\"green\">+2.5%</font> and Dana (NYSE:<a href='https://seekingalpha.com/symbol/DAN' title='Dana Incorporated'>DAN</a>) <font color=\"green\">+2.0%</font>.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3448044-toyota-doubles-hybrids\" target=\"_blank\">Toyota doubles down on hybrids</a> (April 3)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448090\" data-linked=\"Auto parts stocks break higher\" data-tweet=\"$CTTAF $VNE $ADNT - Auto parts stocks break higher https://seekingalpha.com/news/3448090-auto-parts-stocks-break-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/3448090-auto-parts-stocks-break-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448087\" data-ts=\"1554299196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448087-inovio-up-1-on-encouraging-inominus-3106-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio up 1% on encouraging INO-3106 results</a></h4><ul><li>Inovio Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color=\"green\">+1.4%</font>) is up on light volume in early trade on the heels of <a href=\"https://seekingalpha.com/pr/17465191-inovios-novel-hpv-therapy-inominus-3106-demonstrates-clinical-efficacy-rare-respiratory-tract\" target=\"_blank\">results </a>from a pilot study of INO-3106 in two patients with recurrent respiratory papillomatosis, a rare HPV-associated disease characterized by persistent noncancerous tumor growths in the airways. The data were presented at AACR in Atlanta.</li><li>Surgery to remove the growths, usually multiple times each year, is the only current treatment.</li><li>Following their last dose of INO-3106, a non-invasive immunotherapy, both patients have been surgery-free, one for two years and the other for one year.</li><li>Development is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448087\" data-linked=\"Inovio up 1% on encouraging INO-3106 results\" data-tweet=\"$INO - Inovio up 1% on encouraging INO-3106 results https://seekingalpha.com/news/3448087-inovio-up-1-on-encouraging-inominus-3106-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3448087-inovio-up-1-on-encouraging-inominus-3106-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448073\" data-ts=\"1554297982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VERI\" target=\"_blank\">VERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448073-veritoneplus-7_5-jmp-sees-79-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veritone +7.5% as JMP sees 79% upside</a></h4><ul>   <li>Veritone (NASDAQ:<a href='https://seekingalpha.com/symbol/VERI' title='Veritone, Inc.'>VERI</a>) is <font color=\"green\">up 7.5%</font> premarket following an initiation at Market Outperform by JMP.</li>    <li>Analyst Patrick Walravens has a price target of $10, implying 79% upside.</li>    <li>The stock is <font color=\"green\">up 46.8%</font> over the past quarter, but its 12-month performance is <font color=\"red\">-60.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448073\" data-linked=\"Veritone +7.5% as JMP sees 79% upside\" data-tweet=\"$VERI - Veritone +7.5% as JMP sees 79% upside https://seekingalpha.com/news/3448073-veritoneplus-7_5-jmp-sees-79-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3448073-veritoneplus-7_5-jmp-sees-79-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448072\" data-ts=\"1554297851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448072-trovagene-down-3-premarket-on-onvansertib-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trovagene down 3% premarket on onvansertib data</a></h4><ul><li>Nano cap Trovagene (NASDAQ:<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a>) is down <font color=\"red\">3%</font> premarket on light volume, poised to add to yesterday's <font color=\"red\">13%</font> drop, after it announced <a href=\"https://seekingalpha.com/pr/17462833-early-data-phase-2-trial-indicates-activity-onvansertib-prostate-cancer-patients-showing\" target=\"_blank\">preliminary data</a> at AACR on its Phase 2 clinical trial evaluating onvansertib, combined with Johnson &amp; Johnson's Zytiga (abiraterone acetate)/prednisone, in patients with metastatic castration-resistant prostate cancer.</li><li>Early PSA response was observed in two patients with the addition of onvansertib, one who achieved disease control and a 30% decrease in tumor size.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448072\" data-linked=\"Trovagene down 3% premarket on onvansertib data\" data-tweet=\"$TROV - Trovagene down 3% premarket on onvansertib data https://seekingalpha.com/news/3448072-trovagene-down-3-premarket-on-onvansertib-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3448072-trovagene-down-3-premarket-on-onvansertib-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448071\" data-ts=\"1554297707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448071-stm-optt-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">STM, OPTT among premarket gainers</a></h4><ul><li>Evogene (NASDAQ:<a href='https://seekingalpha.com/symbol/EVGN' title='Evogene Ltd.'>EVGN</a>) <font color=\"green\">+34%</font> on <a href=\"https://seekingalpha.com/news/3448041-evogene-develop-medical-cannabis-products-shares-34-percent-premarket\" target=\"_blank\">develop</a> medical cannabis products.</li><li>InspireMD (NYSEMKT:<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a>) <font color=\"green\">+23%</font>.</li><li>Ocean Power Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"green\">+22%</font>.</li><li>Aptinyx (NASDAQ:<a href='https://seekingalpha.com/symbol/APTX' title='Aptinyx Inc.'>APTX</a>) <font color=\"green\">+11%</font> on NYX-458 <a href=\"https://seekingalpha.com/news/3448040-aptinyx-13-percent-premarket-nyxminus-458-data-parkinsons\" target=\"_blank\">data</a> in Parkinson's.</li><li>Tetraphase Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals, Inc.'>TTPH</a>) <font color=\"green\">+9%</font> on <a href=\"https://seekingalpha.com/pr/17464855-tetraphase-pharmaceuticals-presents-preclinical-data-tpminus-2846-novel-drug-candidate-acute\" target=\"_blank\">announcing</a> data from its preclinical program for TP-2846.</li><li>MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"green\">+8%</font>.</li><li>Riot Blockchain (NASDAQ:<a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>) <font color=\"green\">+8%</font> on FY <a href=\"https://seekingalpha.com/news/3447949-riot-blockchain-beats-revenue\" target=\"_blank\">results</a>.</li><li>Nxt-ID (NASDAQ:<a href='https://seekingalpha.com/symbol/NXTD' title='Nxt-ID, Inc.'>NXTD</a>) <font color=\"green\">+8%</font> as its subsidiary FitPay <a href=\"https://seekingalpha.com/pr/17464882-nxt-id-subsidiary-fitpay-begins-pre-order-shipments-flip-contactless-payment-device-bitcoin\" target=\"_blank\">begins pre-order shipments</a> of Flip.</li><li>Intelsat S.A. (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) <font color=\"green\">+7%</font>. as JPMorgan <a href=\"https://seekingalpha.com/news/3448065-intelsat-plus-7-percent-jpmorgan-upgrades-c-band-potential\" target=\"_blank\">upgrades</a> on C-Band potential.</li><li>Dave &amp; Buster's Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/PLAY' title='Dave & Buster&#39;s Entertainment, Inc.'>PLAY</a>) <font color=\"green\">+6%</font> on Q4 <a href=\"https://seekingalpha.com/news/3447890-dave-and-busters-beats-0_11-beats-revenue\" target=\"_blank\">earnings</a>.</li><li>STMicroelectronics N.V. (NYSE:<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics N.V.'>STM</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448071\" data-linked=\"STM, OPTT among premarket gainers\" data-tweet=\"$EVGN $NSPR $OPTT - STM, OPTT among premarket gainers https://seekingalpha.com/news/3448071-stm-optt-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448071-stm-optt-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448070\" data-ts=\"1554297648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COMM\" target=\"_blank\">COMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448070-commscopeplus-4_5-raymond-james-moves-to-strong-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CommScope +4.5% as Raymond James moves to Strong Buy</a></h4><ul>   <li>CommScope (NASDAQ:<a href='https://seekingalpha.com/symbol/COMM' title='CommScope Holding Company, Inc.'>COMM</a>) is <font color=\"green\">up 4.5%</font> in premarket trading after a bullish upgrade from Raymond James, to Strong Buy from Outperform.</li>    <li>Analyst Simon Leopold has his price target set at $32, implying 40% upside.</li>    <li>Shares are <font color=\"red\">down 42.1%</font> over the past 12 months, but reversed an end-of-2018 decline and are <font color=\"green\">up 39.3%</font> YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448070\" data-linked=\"CommScope +4.5% as Raymond James moves to Strong Buy\" data-tweet=\"$COMM - CommScope +4.5% as Raymond James moves to Strong Buy https://seekingalpha.com/news/3448070-commscopeplus-4_5-raymond-james-moves-to-strong-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3448070-commscopeplus-4_5-raymond-james-moves-to-strong-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448066\" data-ts=\"1554297377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OPTT\" target=\"_blank\">OPTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448066-ocean-power-soars-on-contract-announcement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ocean Power soars on contract announcement</a></h4><ul><li>Ocean Power (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTT' title='Ocean Power Technologies, Inc.'>OPTT</a>) <font color=\"green\">+42%</font> premarket after <a href=\"https://seekingalpha.com/pr/17465285-ocean-power-technologies-wins-contract-leading-oil-and-gas-operator\" target=\"_blank\">signing</a> a contract with a leading oil and gas exploration and production company to complete a 12-week paid feasibility study that will examine the use of OPT's products and services in monitoring subsea wells during decommissioning activities.</li><li>The work was issued under a recently announced Master Service Contract and OPT will execute the contract under its Innovation &amp; Support Services vertical.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448066\" data-linked=\"Ocean Power soars on contract announcement\" data-tweet=\"$OPTT - Ocean Power soars on contract announcement https://seekingalpha.com/news/3448066-ocean-power-soars-on-contract-announcement?source=tweet\" data-url=\"https://seekingalpha.com/news/3448066-ocean-power-soars-on-contract-announcement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448065\" data-ts=\"1554297352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448065-intelsatplus-7-jpmorgan-upgrades-on-c-band-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat +7% as JPMorgan upgrades on C-Band potential</a></h4><ul>   <li>Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat S.A.'>I</a>) is <font color=\"green\">up 7%</font> premarket following an upgrade to Overweight at JPMorgan, which sees the potential for \"substantial\" proceeds from spectrum sales by the company and its C-Band Alliance.</li>    <li>Some kind of market-based approach will move that spectrum from the C-Band Alliance (which includes SES (<a href='https://seekingalpha.com/symbol/SGBAF' title='SES S.A.'>OTCPK:SGBAF</a>)) into the hands of wireless carriers over the next five years, analyst Philip Cusick writes. And FCC approval could come as soon as mid-year though it will likely take longer.</li>    <li>His base case has 180 MHz overall being sold to carriers (AT&amp;T, T-Mobile and \"motivated\" Verizon) for $0.25/MHz-POP, or $15B. Intelsat's allocation is currently about 45%. (h/t Bloomberg)</li>    <li>His price target is $27, implying 76% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448065\" data-linked=\"Intelsat +7% as JPMorgan upgrades on C-Band potential\" data-tweet=\"$I $SGBAF - Intelsat +7% as JPMorgan upgrades on C-Band potential https://seekingalpha.com/news/3448065-intelsatplus-7-jpmorgan-upgrades-on-c-band-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3448065-intelsatplus-7-jpmorgan-upgrades-on-c-band-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448064\" data-ts=\"1554297227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNCE\" target=\"_blank\">JNCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448064-jounce-up-5-on-jtxminus-8064-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jounce up 5% on JTX-8064 data</a></h4><ul><li>Jounce Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/JNCE' title='Jounce Therapeutics, Inc.'>JNCE</a>) is up <font color=\"green\">5%</font> premarket on light volume in reaction to <a href=\"https://seekingalpha.com/pr/17464992-jounce-therapeutics-presents-preclinical-data-jtxminus-8064-program-2019-american-association\" target=\"_blank\">preclinical data</a> on JTX-8064 presented at AACR in Atlanta.</li><li>The results supported the potential effect of JTX-8064, a monoclonal antibody, of inducing an anti-tumor immune response by binding to (inhibiting) a protein called LILRB2 (leukocyte immunoglobulin like receptor B2). When LILRB2 binds to certain molecules it suppresses immune cells called macrophages.</li><li>Phase 1 development should commence late this year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448064\" data-linked=\"Jounce up 5% on JTX-8064 data\" data-tweet=\"$JNCE - Jounce up 5% on JTX-8064 data https://seekingalpha.com/news/3448064-jounce-up-5-on-jtxminus-8064-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3448064-jounce-up-5-on-jtxminus-8064-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448062\" data-ts=\"1554296941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448062-gme-and-adxs-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GME and ADXS among premarket losers</a></h4><ul><li>Fusion Connect (NASDAQ:<a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a>) <font color=\"red\">-82%</font> as audit problems prompt Chapter 11 analyst warning.</li><li>Advaxis (NASDAQ:<a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a>) <font color=\"red\">-29%</font> on <a href=\"https://seekingalpha.com/news/3448011-advaxis-26-percent-pricing-stock-offering\" target=\"_blank\">pricing</a> stock offering.</li><li>AVEO Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a>) <font color=\"red\">-21%</font> on <a href=\"https://seekingalpha.com/news/3447993-aveo-10-percent-premarket-fotivda-authorization-risk\" target=\"_blank\">Fotivda</a> authorization risk.</li><li>GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) <font color=\"red\">-13%</font> on <a href=\"https://seekingalpha.com/news/3447892-gamestop-beats-0_02-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>TRACON Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TCON' title='TRACON Pharmaceuticals, Inc.'>TCON</a>) <font color=\"red\">-9%</font>.</li><li>DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"red\">-8%</font> on <a href=\"https://seekingalpha.com/news/3448003-dropcar-reports-q4-results\" target=\"_blank\">Q4 earnings</a>.</li><li>Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448062\" data-linked=\"GME and ADXS among premarket losers\" data-tweet=\"$FSNN $ADXS $AVEO - GME and ADXS among premarket losers https://seekingalpha.com/news/3448062-gme-and-adxs-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3448062-gme-and-adxs-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448058\" data-ts=\"1554296812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSNN\" target=\"_blank\">FSNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448058-fusion-connectminus-83-audit-problems-prompt-chapter-11-analyst-warning\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fusion Connect -83% as audit problems prompt Chapter 11 analyst warning</a></h4><ul><li>Fusion Connect (NASDAQ:<a href='https://seekingalpha.com/symbol/FSNN' title='Fusion Connect, Inc.'>FSNN</a>) <font color=\"red\">-83.3%</font> pre-market after disclosing it would be <a href=\"https://www.sec.gov/Archives/edgar/data/1071411/000165495419003980/fsnn_8k.htm\" target=\"_blank\">unable to file its 2018 annual report on time</a> due to the need for additional time to quantify the impact of Birch's accounting errors.</li><li>The actual amount of necessary financial restatements will not be known until all audit work is completed, but FSNN currently estimates restatements of $2.3M-$3M for FY 2017, $3.4M-$4.1M for the September 2018 quarter and $1.7M-$2.3M for the June 2018 quarter.</li><li>B. Riley FBR downgrades FSNN to Neutral from Buy and slashes its stock price target to $0.75 from $9.75, saying the company's options are limited, given its financial leverage and limited access to capital, and a formal Chapter 11 reorganization \"<a href=\"https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+B.RileyFBR+Downgrades+Fusion+Telecommunications+International+%28FSNN%29+to+Neutral/15333569.html\" target=\"_blank\">appears to be a material possibility</a>.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3448058\" data-linked=\"Fusion Connect -83% as audit problems prompt Chapter 11 analyst warning\" data-tweet=\"$FSNN - Fusion Connect -83% as audit problems prompt Chapter 11 analyst warning https://seekingalpha.com/news/3448058-fusion-connectminus-83-audit-problems-prompt-chapter-11-analyst-warning?source=tweet\" data-url=\"https://seekingalpha.com/news/3448058-fusion-connectminus-83-audit-problems-prompt-chapter-11-analyst-warning\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448057\" data-ts=\"1554296518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHFS\" target=\"_blank\">CHFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448057-chf-solutions-up-3-on-aquadex-patent-application\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CHF Solutions up 3% on Aquadex patent application</a></h4><ul> <li>CHF Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a>) <a href=\"https://seekingalpha.com/pr/17465055-chf-solutions-submits-patent-application-pediatric-use-aquadex-flexflow-system\" target=\"_blank\">submits</a> a method of use application to the USPTO for pediatric use of its Aquadex Flex Flow System.</li>   <li>Illustrative claims in the application include customizable circuit volume for optimizing pediatric patient hemodynamics and a mechanism to ensure the safety of pediatric patients.</li><li>Shares are up 3% premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3448057\" data-linked=\"CHF Solutions up 3% on Aquadex patent application\" data-tweet=\"$CHFS - CHF Solutions up 3% on Aquadex patent application https://seekingalpha.com/news/3448057-chf-solutions-up-3-on-aquadex-patent-application?source=tweet\" data-url=\"https://seekingalpha.com/news/3448057-chf-solutions-up-3-on-aquadex-patent-application\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448052\" data-ts=\"1554295682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/URBN\" target=\"_blank\">URBN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448052-urban-outfittersplus-2-after-d-davidson-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Urban Outfitters +2% after D.A. Davidson nod</a></h4><ul> <li>Urban Outfitters (NASDAQ:<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a>) perks up in early trading after D.A. Davidson lifts the retailer to a Buy rating from Neutral.</li> <li>\"The modest, but high quality growth potential, wrapped in the clearer path to margin turnaround, makes this story attractive given the company's current depressed valuation,\" writes analyst John Morris.</li> <li>The firm lifts its price target on URBN to $36 from $30. Shares have traded in a range of $27.60 to $52.50 over the last 52 weeks.</li> <li>URBN <font color=\"green\">+2.06%</font> premarket to $31.29.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448052\" data-linked=\"Urban Outfitters +2% after D.A. Davidson nod\" data-tweet=\"$URBN - Urban Outfitters +2% after D.A. Davidson nod https://seekingalpha.com/news/3448052-urban-outfittersplus-2-after-d-davidson-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3448052-urban-outfittersplus-2-after-d-davidson-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448050\" data-ts=\"1554295623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACHN\" target=\"_blank\">ACHN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448050-achillion-achieves-enrollment-milestone-in-phase-2-trials-for-c3g\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achillion achieves enrollment milestone in phase 2 trials for C3G</a></h4><ul> <li>Achillion Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHN' title='Achillion Pharmaceuticals, Inc.'>ACHN</a>) has <a href=\"https://seekingalpha.com/pr/17464657-achillion-announces-enrollment-milestone-phase-2-trials-c3-glomerulopathy\" target=\"_blank\">enrolled</a> 23 patients in Phase 2 ACH-4471 six and 12-month clinical trials for patients with C3 glomerulopathy (C3G), a disease affecting the kidney for which there is no approved therapy.</li>      <li>The Company plans to present data from these two Phase 2 trials to FDA in Q4.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li>            </ul><div class=\"tiny-share-widget\" data-id=\"3448050\" data-linked=\"Achillion achieves enrollment milestone in phase 2 trials for C3G\" data-tweet=\"$ACHN - Achillion achieves enrollment milestone in phase 2 trials for C3G https://seekingalpha.com/news/3448050-achillion-achieves-enrollment-milestone-in-phase-2-trials-for-c3g?source=tweet\" data-url=\"https://seekingalpha.com/news/3448050-achillion-achieves-enrollment-milestone-in-phase-2-trials-for-c3g\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448049\" data-ts=\"1554295595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLT\" target=\"_blank\">TLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448049-weak-jobs-numbers-dont-dent-rates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weak jobs numbers don&#39;t dent rates</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3448028-adp-jobs-just-129k-march\" target=\"_blank\">The ADP reported</a> just a 129K job gain in March, well short of expectations in the 165K-175K range.</li><li>The bond market is mostly yawning at the numbers, with the 10-year Treasury yield holding onto its roughly four basis point gain for the day to 2.515%. One week ago, the yield had touched as low as 2.37%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"red\">-0.7%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"green\">+1.4%</font></li><li>The government's nonfarm payroll report for March is due on Friday.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448049\" data-linked=\"Weak jobs numbers don&#39;t dent rates\" data-tweet=\"$TLT $TBT - Weak jobs numbers don&#39;t dent rates https://seekingalpha.com/news/3448049-weak-jobs-numbers-dont-dent-rates?source=tweet\" data-url=\"https://seekingalpha.com/news/3448049-weak-jobs-numbers-dont-dent-rates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448048\" data-ts=\"1554295576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448048-amex-deal-boosts-chances-for-berkshire-buying-delta-air-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmEx deal boosts chances for Berkshire buying Delta Air: Stifel</a></h4><ul><li>Delta Air Lines' (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) renewal of its 23-year partnership with American Express<a href=\"https://seekingalpha.com/pr/17464842-american-express-sap-ariba-join-forces-deliver-true-end-end-procure-pay-process-corporate\" target=\"_blank\"> boosts the potential</a> for Berkshire Hathaway (NYSE:<a href='https://seekingalpha.com/symbol/BRK.B' title='Berkshire Hathaway Inc.'>BRK.B</a>) to buy the airline, Stifel analyst Joseph DeNardi writes.</li><li>Delta<font color=\"green\"> rises 1.0%</font> in premarket trading.</li><li>With the renewal, the airline is on track to be one of the world's most valuable marketing companies, the analyst writes in note.</li><li>The timing was \"earlier than we had thought and the improvement in revenue and economics are significantly better than we were expecting,\" he added.</li><li>Speculation about Berkshire buying Delta isn't new. Last month, Berkshire founder and Chairman Warren Buffett said his stake in Delta had risen over his comfort level by mistake.</li><li>Berkshire is the top holder in both Delta (over 10%) and American Express (18%).</li><li>Related ticker: <a href='https://seekingalpha.com/symbol/BRK.A' title='Berkshire Hathaway Inc.'>BRK.A</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3447716-american-express-delta-air-lines-renew-partnership-2029\" target=\"_blank\">American Express, Delta Air Lines renew partnership through 2029</a> (April 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448048\" data-linked=\"AmEx deal boosts chances for Berkshire buying Delta Air: Stifel\" data-tweet=\"$DAL $BRK.B $DAL - AmEx deal boosts chances for Berkshire buying Delta Air: Stifel https://seekingalpha.com/news/3448048-amex-deal-boosts-chances-for-berkshire-buying-delta-air-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3448048-amex-deal-boosts-chances-for-berkshire-buying-delta-air-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448047\" data-ts=\"1554295495\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPMC\" target=\"_blank\">BPMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448047-morgan-stanley-likes-blueprint-medicines-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morgan Stanley likes Blueprint Medicines in premarket analyst action</a></h4><ul><li>Blueprint Medicines (NASDAQ:<a href='https://seekingalpha.com/symbol/BPMC' title='Blueprint Medicines Corporation'>BPMC</a>) initiated with Overweight rating and $112 (34% upside) price target at Morgan Stanley.</li><li>IRhythm Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/IRTC' title='iRhythm Technologies, Inc.'>IRTC</a>) upgraded to Buy with an $80 (15% upside) price target at BTIG Research citing its attractive valuation after the recent selloff. Shares up <font color=\"green\">2%</font> premarket.</li><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>): downgraded to Sector Perform at RBC. Shares down <font color=\"red\">1%</font> premarket.</li><li>Meridian Bioscience (NASDAQ:<a href='https://seekingalpha.com/symbol/VIVO' title='Meridian Bioscience, Inc.'>VIVO</a>) downgraded to Sell with an $11 (23% downside risk) price target at Canaccord Genuity after the company <a href=\"https://seekingalpha.com/news/3447690-meridian-bioscience-sees-50m-q4-revenue\" target=\"_blank\">revised</a> (down) its F2019 outlook. Shares are off <font color=\"red\">8%</font> premarket.</li><li>Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) downgraded to Hold with a $60 (8% upside) price target at Loop Capital after its FQ2 miss. Shares up a fraction premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448047\" data-linked=\"Morgan Stanley likes Blueprint Medicines in premarket analyst action\" data-tweet=\"$BPMC $IRTC $INCY - Morgan Stanley likes Blueprint Medicines in premarket analyst action https://seekingalpha.com/news/3448047-morgan-stanley-likes-blueprint-medicines-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3448047-morgan-stanley-likes-blueprint-medicines-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448041\" data-ts=\"1554294727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EVGN\" target=\"_blank\">EVGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448041-evogene-to-develop-medical-cannabis-products-shares-up-34-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Evogene to develop medical cannabis products; shares up 34% premarket</a></h4><ul><li>Evogene (NASDAQ:<a href='https://seekingalpha.com/symbol/EVGN' title='Evogene Ltd.'>EVGN</a>) has <a href=\"https://seekingalpha.com/pr/17464758-evogene-develop-next-generation-medical-cannabis-products-new-subsidiary-canonic-ltd\" target=\"_blank\">established</a> a new subsidiary \u2013 Canonic Ltd., to develop next generation medical cannabis products.</li><li>Canonic's initial activities will focus on creating improved cannabis varieties by addressing yield, stability and specific metabolite composition.</li><li>These development efforts will be based on the utilization of Evogene's broadly applicable leading Computational Predictive Biology platform.</li>                   <li>Shares are up <font color=\"green\">34%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3448041\" data-linked=\"Evogene to develop medical cannabis products; shares up 34% premarket\" data-tweet=\"$EVGN - Evogene to develop medical cannabis products; shares up 34% premarket https://seekingalpha.com/news/3448041-evogene-to-develop-medical-cannabis-products-shares-up-34-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3448041-evogene-to-develop-medical-cannabis-products-shares-up-34-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448040\" data-ts=\"1554294642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTX\" target=\"_blank\">APTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448040-aptinyx-up-13-premarket-on-nyxminus-458-data-in-parkinsons\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aptinyx up 13% premarket on NYX-458 data in Parkinson&#39;s</a></h4><ul><li>Aptinyx (NASDAQ:<a href='https://seekingalpha.com/symbol/APTX' title='Aptinyx Inc.'>APTX</a>) is up <font color=\"green\">13%</font> premarket on robust volume in reaction to <a href=\"https://seekingalpha.com/pr/17464801-data-parkinson-s-disease-model-non-human-primates-demonstrate-reversal-cognitive-deficits\" target=\"_blank\">preclinical data</a> on its NMDA receptor modulator NYX-458. The results were presented at the International Conference on Alzheimer's &amp; Parkinson's Diseases in Lisbon, Portugal.</li><li>In a non-human primate model of Parkinson's disease, a single dose of NYX-458 produced significant sustainable improvements in cognitive performance across a battery of tests. When administered alone or with levodopa, there were no adverse effects on motor symptoms or observed interference with levodopa. No tolerability issued were reported.</li><li>Results from a Phase 1 in-human study assessing the safety, tolerability, pharmacokinetics and CNS exposure of NYX-458 should be available later this quarter. A Phase 2 should launch in H2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3448040\" data-linked=\"Aptinyx up 13% premarket on NYX-458 data in Parkinson&#39;s\" data-tweet=\"$APTX - Aptinyx up 13% premarket on NYX-458 data in Parkinson&#39;s https://seekingalpha.com/news/3448040-aptinyx-up-13-premarket-on-nyxminus-458-data-in-parkinsons?source=tweet\" data-url=\"https://seekingalpha.com/news/3448040-aptinyx-up-13-premarket-on-nyxminus-458-data-in-parkinsons\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3448039\" data-ts=\"1554294548\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3448039-nomura-new-buy-on-intels-eps-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura new Buy on Intel&#39;s EPS potential</a></h4><ul><li>Nomura initiates Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) at Buy citing its lead in \"high-growth markets\" with the potential to see EPS growth exceed top-line growth.</li><li>The firm forecasts 8% to 10% long-term sales growth with margin expansion and share count reductions potentially boosting the EPS growth.</li><li>Price target set at $65.</li><li>Intel shares are <font color=\"green\">up 1.3%</font> pre-market to $55.08 on a busy morning of news for the industry.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3447868-intel-unveils-cascade-lake-processors\" target=\"_blank\">Intel unveils Cascade Lake processors</a> (April 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3447939-intel-hires-qualcomms-davis-new-cfo\" target=\"_blank\">Intel hires Qualcomm's Davis as new CFO</a> (April 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3448024-tsmcs-7nm-orders-grow-smartphone-demand\" target=\"_blank\">TSMC's 7nm orders grow on smartphone demand</a> (April 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3448039\" data-linked=\"Nomura new Buy on Intel&#39;s EPS potential\" data-tweet=\"$INTC - Nomura new Buy on Intel&#39;s EPS potential https://seekingalpha.com/news/3448039-nomura-new-buy-on-intels-eps-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3448039-nomura-new-buy-on-intels-eps-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}